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Abstract
Routinely, athletes and coaches pursue novel nutritional strategies in an attempt to support
exercise training techniques and/or enhance athletic performance. Body carbohydrate (CHO)
stores are limited so strategies to enhance fat use and spare CHO during exercise and thus,
attenuate the onset of fatigue are commonplace. It has been suggested that oral exogenous
ketone administration is ergogenic not only by altering exercise metabolism (sparing CHO),
but also by improving exercise cognitive function as well as enhancing post-exercise
glycogen resynthesis. However, data supporting these claims are limited and contradictory.
Therefore, the purpose of this dissertation was to explore the role of exogenous ketone type,
i.e., salts (KS) vs ketone monoester (KME) supplementation on various aspects of
performance to provide more insight into the current body of evidence. Study 1 showed that
relative to an isoenergetic control, acute ingestion of both a caffeinated KS supplement and
the same KS supplement without caffeine improved Wingate peak power output, following a
20 km time trial (TT20km), while only the caffeinated supplement improved the best effort
TT20km. Therefore, these performance benefits were likely due to the added caffeine or
taurine, not the ketones. Study 2 demonstrated that co-ingestion of KME and CHO after
glycogen lowering exercise (GLE) vs isoenergetic CHO alone, resulted in no significant
differences in any of the exercise performance parameters suggesting that glycogen
resynthesis post exercise was not enhanced with KME. Study 3 revealed that, following
induced mental fatigue, KME attenuated the decline in cognitive function during exercise in
a complex reaction test, when compared to a non-caloric placebo. Taken together, these data
demonstrate that 1) acute KS supplementation is not likely to be ergogenic nor detrimental
for intense exercise performance, 2) KME supplementation may improve some aspects of
cognitive function during exercise, and 3) KME supplementation has little effect on postexercise glycogen synthesis following prior GLE. Relative to the ergogenic potential of
ketones for athletes, these data are intriguing, but more study is needed to assess fully
whether and how ketone supplements are beneficial for athletes.

Keywords: post-exercise recovery, ketosis, ketonemia, cognitive function, mental
fatigue.
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Summary for Lay Audience
Carbohydrates (CHO - sugars and starches) are an important fuel for brain and muscle during
exercise but unfortunately body stores are limited and reduction of these stores is linked to
fatigue. Athletes and coaches often seek procedures that can help support exercise training or
improve exercise performance, so strategies to increase fat use and/or spare CHO during
exercise are common. Some researchers believe that oral ketone administration can help
improve exercise performance not only by sparing exercise CHO use, but also by improving
exercise cognitive function (decision making, reaction time, etc.), as well as increasing body
CHO stores during recovery following exercise. However, evidence to support the veracity of
these claims is both modest and inconsistent. Therefore, the purpose of this dissertation was
to explore the role of oral ketone type, i.e., salts (KS) vs ketone monoester (KME)
supplementation on different aspects of performance to provide more insight into this
research area. Study 1 showed that drinking a caffeinated, KS supplement and the same KS
supplement without caffeine improved performance of an intense 30-sec sprint, after a 20 km
cycling race (TT20km), while only the caffeinated supplement improved the TT20km. These
performance benefits were likely due to the added caffeine or taurine, not the ketones. Study
2 demonstrated that drinking KME and CHO after intense exercise resulted in no differences
in exercise performance 4 h later, compared to drinking CHO alone. This implies that
refilling of CHO stores after exercise was not better with ketone supplementation. Study 3
showed that, after inducing mental fatigue, KME reduced the deterioration in cognitive
function during exercise in a complex reaction test. Taken together, these data demonstrate
that 1) KS supplementation likely does not improve nor worsen intense exercise
performance, 2) KME supplementation may improve some aspects of cognitive function
during exercise, 3) KME supplementation has little effect on refilling CHO stores after
exercise. Regarding the ability of ketone supplements to improve performance in athletes,
these data are intriguing, but more study is needed to evaluate fully if and how ketone
supplements are beneficial for athletes.
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Chapter 1
1

General Introduction
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1.1 Introduction
Carbohydrates (CHO) and fat represent important fuels for energy during exercise (Van
Loon et al., 2001). The relative contribution of these substrates for energy during exercise
depends on factors such as intensity and duration (Van Loon et al., 2001), diet
(McSwiney et al., 2018), amongst others (Coggan and Coyle, 1991; Van Loon et al.,
1999). Moreover, reduction of CHO stores has been associated with fatigue, which
produces a decrement in work rate and may also lead to impaired cognitive function, both
important aspects of sports performance (Baker et al., 2014). Unfortunately, CHO stores
represent a finite source of energy that can be depleted in 1-2 h of exercise or even more
quickly with intense, repeated exercise (Hawley and Lackey, 2015). Therefore, athletes
and coaches are constantly pursuing nutritional strategies to support training techniques
and/or enhance athletic performance. Specifically, strategies to increase fat use and/or
help spare CHO during exercise and thus, attenuate the onset of fatigue are
commonplace. Some scientists believe that adapting one’s body to utilize a greater
amount of fat for exercise energy (fat adapted) may be advantageous, because even in
lean individuals, fat represents a virtually unlimited source of energy (Sansone et al.,
2018; Volek et al., 2015), unlike CHO.
Over the past decade, there has been a re-emerging interest in adopting high-fat, lowCHO diets or ketogenic diets (KD) with the sole purpose of shifting metabolism to
increase fat oxidation during exercise, while reducing the reliance on CHO. Adopting this
dietary regime leads to increased ketogenesis (formation of endogenous ketones;
acetoacetate, acetone, and β-hydroxybutyrate). These are lipid-derived molecules
synthesized in the liver that can be oxidized to replace glucose reductions that occur in
response to low CHO diets (Valenzuela et al., 2020). This increased concentration of
ketones in the blood is called nutritional ketosis (Evans et al., 2017) and results after ~3
to 6 d on a high fat or low CHO diet (Paoli et al., 2013). Typical concentrations of
ketones in blood range from 0-0.5 mM whereas nutritional ketosis is defined as a plasma
ketone concentration of ~0.5–3.0 mM, i.e., hyperketonemia (Gibson and Sainsbury,
2017). This is important because ketones can serve as an alternative energy substrate for
peripheral tissue such as muscle and brain (Stubbs et al., 2017). Since they are formed
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from fat metabolism, this energy reservoir is virtually endless as well and can help spare
available CHO. Additionally, the free energy of ATP hydrolysis for ketones has been
shown to be greater than CHO, i.e., ketone bodies are energetically more efficient (Evans
et al., 2017). However, studies have failed to show a clear benefit in performance when
following a ketogenic diet compared to a high CHO diet (Burke, 2021), despite the
outlined advantages of ketones over CHO. This may be because in addition to shifting
metabolism to allow muscles to utilize more fat during exercise (McSwiney et al., 2018),
ketogenic diets also impair rates of muscle glycogenolysis and energy flux (Stellingwerff
et al., 2006), resulting in a reduced capacity for high-intensity ATP regeneration.
Specifically, studies indicate that with the up-regulation of fat utilization for energy, there
is a concomitant reduction in pyruvate dehydrogenase activity (PDH), a key regulatory
enzyme responsible for CHO metabolism (Stellingwerff et al., 2006). Even if athletes
become fat-adapted and load with CHO a day or two preceding competitions, there is no
apparent exercise performance benefit (Burke et al., 2020) likely because of this PDH
down-regulation.
Recently, some nutrient supplement manufacturers have developed exogenous ketone
(EK) supplements in an attempt to address the exercise performance limitations seen with
the ketogenic diet (CHO restriction). Oral administration of EK in healthy adults leads to
an acute state of ketosis that can last up to 3 h (Stubbs et al., 2017). Interestingly, this
acute ketosis allows the study of ketone use under a unique metabolic scenario, i.e., in
combination with high CHO availability. EK have been proposed to have the potential to
improve performance not only by altering metabolism during exercise, but also by
improving aspects of recovery and even cognitive function (Valenzuela et al., 2021).
Consequently, the use of EK has received substantial attention not only from the
scientific community (Evans et al., 2017), but also from elite endurance athletes,
particularly professional cyclists (Valenzuela et al., 2021).
The first to demonstrate the ergogenic potential of EK was Cox et al. (2016). In a series
of studies, these authors showed that supplementing with EK before exercise reduced
muscle glycogen utilization with a concomitant increase in fat oxidation during exercise.
They also showed that this CHO sparing effect resulted in a 2% improved 30 min time

4

trial performance (Cox et al., 2016). In contrast, the results of several subsequent studies
assessing performance have been equivocal (Evans and Egan, 2018; Waldman et al.,
2018; Evans et al., 2019; James and Greer, 2019; Poffe et al., 2020) and any conclusions
around the use of EK and exercise performance remain controversial. Several factors
have been suggested to explain these differing results. Specifically, the heterogeneity in
the literature regarding the ketone type (esters vs salts) and dose (ranging from 106 – 915
mg·kg body mass−1) of the supplement, the small sample sizes (50% of studies using ≤10
participants) studied and the differences in performance tests used have all been
implicated (Valenzuela et al., 2020, Margolis and O’fallon, 2020). Due to differences in
type and dose of ketone used, various degrees of ketosis are reported in the literature, and
this has been identified as a key aspect to determine efficacy of the supplement (Margolis
and O’fallon, 2020).
In addition to exercise performance, EK have been proposed to benefit both cognitive
function and post-exercise recovery. However, only a few studies have been conducted
assessing the efficacy of EK on either cognitive function in exercise or post-exercise
recovery. Further, the results are conflicting and, therefore, it is difficult to draw any
conclusions at present. Clearly, more research is warranted to elucidate the effects of
ketone supplementation.
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2.1 Ketone Metabolism
The process of ketone formation is called ketogenesis and occurs primarily in hepatocytes
(Robinson and Williamson, 1980; Laffel, 1999; Evans et al., 2017; Puchalska and
Crawford, 2017). Ketone bodies (KB) are lipid-derived molecules synthesized in very
small amounts typically, but their synthesis can be upregulated in response to low CHO
availability such as during prolonged fasting, starvation, prolonged exercise where CHO
stores are depleted, uncontrolled diabetes, and/or dietary manipulations to restrict CHO
intake (Robinson and Williamson, 1980; Laffel, 1999; Puchalska and Crawford, 2017).
All of the aforementioned scenarios result in a decrease in hepatic glycogen content and
an increase in the circulating glucagon-to-insulin ratio (Evans et al., 2017). Both cause an
up-regulation of hepatic lipolysis through β-oxidation, a process that results in the
formation of Acetyl-CoA (Ac-CoA) to continue feeding the tricarboxylic acid (TCA)
cycle and generate ATP (Laffel, 1999). In the first step of the TCA cycle, oxaloacetate (a
four-carbon molecule) combines with Ac-CoA (two-carbon molecule) to form citrate
(Laffel, 1999). Oxaloacetate is also a gluconeogenic precursor (Laffel, 1999), thus some
of it is utilized for gluconeogenesis when CHO availability is low and this leads to an
accumulation of Ac-CoA in the mitochondrial matrix of hepatic cells (Evans et al., 2017)
(Figure 2.1).

2.1.1 Ketogenesis
In this metabolic process, the excess Ac-CoA molecules are combined to form 4-carbon
molecules known as ketone bodies (KB), specifically beta-hydroxybutyrate (βHB),
acetoacetate (AcAc) and acetone (Robinson and Williamson, 1980; Laffel, 1999; Evans
et al., 2017) (Figure 2.1). This process is called ketogenesis and involves a short sequence
of reactions that result in the formation of AcAc initially (Laffel, 1999; Puchalska and
Crawford, 2017). There are three possible fates for AcAc after it is formed: 1) the
majority of it is reduced to βHB in an NAD+/NADH-coupled near equilibrium reaction,
in which that equilibrium favours the formation of βHB, 2) small amounts of AcAc can
enter the circulatory system, and 3) some of it can undergo spontaneous decarboxylation
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to form acetone (Laffel, 1999; Puchalska and Crawford, 2017). Once formed, KB,
primarily in the form of βHB, are transported out of hepatocytes into the blood stream via
the solute ligand carrier (SLC) protein 16A (SLC16A) family of monocarboxylate
transporters (Balasse and Fery, 1989; Kahn et al., 2005; Evans et al., 2017), and this leads
to a state of ketosis (Figure 2.2).

Figure 2.1. Metabolism of Ketone Bodies I. Schematic diagram of the process of endogenous
ketone formation (ketogenesis) which occurs in hepatocytes primarily, in response to low glucose
availability.

2.1.2 Ketosis
Ketosis refers to an accumulation of KB in blood (Evans et al., 2017). The concentration
is determined by the rate of hepatic output or rate of release into circulation and the rate
of extra hepatic tissue uptake and utilization (Robinson and Williamson, 1980; Fery and
Balasse, 1983; Laffel, 1999) (Figure 2.2). Under normal conditions and with an adequate
ingestion of CHO, the concentration of KB in blood ranges from 0-0.5 mM (Robinson
and Williamson, 1980; Laffel, 1999; Evans et al., 2017). However, hyperketonemia
(A.K.A. ketosis) can occur with the up-regulation of ketogenesis, which leads to a
greater-than-normal production of KB (Laffel, 1999; Evans et al., 2017). In ketosis, blood
concentrations of KB can range from 0.5 – 8 mM, depending on what is stimulating
ketogenesis. For example, blood concentrations of KB may reach concentrations up to
8mM with starvation (Cahill Jr, 1970). Typically, nutritional ketosis or ketosis attained
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through dietary manipulations reach blood KB concentrations of ~0.5–3.0 mM (Gibson
and Sainsbury, 2017). It is important to note that nutritional ketosis is a safe physiological
state, proven to be harmless and associated with a number of therapeutic benefits (Paoli
et al., 2013). In contrast, ketoacidosis is a pathological state where blood concentrations
of KB can increase up to 20 mM (Laffel, 1999; Puchalska and Crawford, 2017). The
problem with this is that KB have a Pka of ~4-5 (Puchalska and Crawford, 2017) which
means they are naturally acidic so when they are present in such high concentrations,
they become life-threatening since blood pH can be reduced significantly (Laffel, 1999).
Ketoacidosis occurs mainly in diabetics (mostly type 1) and severe alcoholics (Laffel,
1999). As alluded to earlier, insulin and glucagon are powerful hormones that regulate
ketogenesis (Robinson and Williamson, 1980; Evans et al., 2017). Specifically, insulin
inhibits the protein FOXA2, while the hormone glucagon activates it (Wolfrum et al.,
2004; Puchalska and Crawford, 2017). This protein will in turn activate the primary
regulator of KB production, the enzyme HMG-CoA synthase in the mitochondria of liver
cells (Hegardt, 1998; Wolfrum et al., 2004). In type 1 diabetics, insulin production is
impaired so there is a risk to accumulate extremely high KB concentrations, reaching a
state of diabetic ketoacidosis (Laffel, 1999). Similarly, alcohol metabolism increases AcCoA formation and suppresses gluconeogenesis (Laffel, 1999). This coupled with
starvation (alcohol taking precedence over food) leads to transient low insulin
concentrations that can cause severe alcoholics to reach a state of alcoholic ketoacidosis
(Laffel, 1999). In healthy individuals, insulin is secreted as the concentration of KB in
blood increases, and this allows ketogenesis to slow down to maintain pH in the normal
range (Mullins et al., 2011). This standard feedback control mechanism is important to
maintain a state of ketosis and prevent ketoacidosis. Once KB circulate in the
bloodstream, they can be transported to extrahepatic tissues where they move
intracellularly favoring the concentration gradient and are ultimately oxidised in a
metabolic process called ketolysis (Puchalska and Crawford, 2017).

2.1.3 Peripheral Tissue Ketones Utilization (Ketolysis)
Ketolysis refers to the metabolic process involving conversion of KB into energy to fuel
metabolic activity of different tissues (Laffel, 1999; Evans et al., 2017). Ketolysis
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converts AcAc and βHB back into two molecules of Ac-Coa that can then enter the TCA
cycle for ATP regeneration (Laffel, 1999) (Figure 2.2). Acetone, the third KB, is
eliminated through respiration and is responsible for the sweet breath odour characteristic
of ketosis/ketoacidosis (Paoli et al., 2013). Once KB are synthesized in the liver, they are
released into circulation (primarily in the form of βHB) where they travel to fuel other
tissues. Although the liver produces KB, it cannot use them for energy because
hepatocytes lack an important rate limiting enzyme for ketolysis, Succinyl-Coa: 3Ketoacid Coenzyme A Transferase (OXCT) (Robinson and Williamson, 1980). The
uptake of KB into the mitochondrial matrix of peripheral tissue is mediated by
monocarboxylate 1 transporters and is dependent on the rate of appearance of KB in the
blood (Evans et al., 2017). Early studies used a variety of fasting protocols as well as
infusion of radiolabelled ketone tracers and arteriovenous difference to quantify KB
metabolism. These studies showed that extra hepatic tissue such as brain, kidney, as well
as both skeletal and cardiac muscle have been identified as sites of KB utilization.
Further, skeletal muscle is the major site for ketolysis because a large proportion of the
human body (~40% of body mass) is composed of skeletal muscle (Hagenfeldt and
Wahren, 1968; Owen and Reichard, 1971, Mikkelsen et al., 2015) despite the fact that
heart and kidney displayed the greatest activity of the ketolytic rate limiting enzyme
OXCT (Robinson and Williamson, 1980). In addition, Balasse and Fery (1989)
demonstrated that skeletal muscle extraction rates saturate between ~1-2 mM, meaning
that as the concentration increases above these values, the total relative KB extraction in
skeletal muscle decreases. Interestingly, KB have been shown to be more efficient for
energy production even when compared to CHO. Specifically, when βHB (main KB
involved in ketolysis) is burned in a bomb calorimeter, it yields 31% more energy per C2
unit compared to pyruvate, the end product in CHO metabolism (Veech, 2004).
Furthermore, a 28% increase in the hydraulic efficiency of perfused working hearts was
shown when cardiac muscle metabolizes βHB compared to glucose. This increase in
efficiency has been explained partly by the greater heat combustion of βHB (Veech,
2004). Importantly, KB utilization in skeletal muscle has been shown to increase as much
as fivefold during exercise, when in a state of ketosis (Hagenfeldt and Wahren, 1968;
Fery and Balasse, 1983; Balasse and Fery, 1989). Therefore, reaching a state of ketosis
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may be an important strategy to improve exercise performance, but how that
physiological state is achieved (endogenously or exogenously – Figure 2.2) can have
important implications.

Figure 2.2. Metabolism of Ketone Bodies II. Schematic diagram showing how blood KB can be
increased endogenously (ketogenesis) or exogenously via supplementation as well as how
ketones can be used for energy by extrahepatic tissue (ketolysis).

2.2 Basis for Ketone Supplementation
In the last few decades, nutrition experts have focused primarily on CHO intake to
optimize exercise performance (Hawley and Leckey, 2015). Nonetheless, CHO stores can
be depleted within 1-2 h of intense exercise, and this depletion is coincident with the
onset of fatigue (Hawley and Leckey, 2015). As such, fatigue becomes an inevitable
feature in sports or other activities of moderate to long durations. So, nutrition strategies
to attenuate or prevent fatigue-derived decrements in performance are always of interest.
As discussed, KB are derived from fat metabolism, and can serve as an alternative fuel
for peripheral tissue (Robinson and Williamson, 1980; Veech, 2004). Unlike CHO, fat
represents a rather limitless source of energy (hundreds of thousands of calories) and
therefore decreasing the reliance on CHO during exercise could be an effective approach
to improve athletic performance (Volek et al., 2015). Further, increases in KB blood
concentration, i.e., nutritional ketosis, is achieved easily through dietary manipulations
such as the use of ketogenic diets (KD) (Volek et al., 2015). However, the KD requires an
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individual to consume a very high percentage of calories from fat (70 - 80%) while
restricting CHO intake (5 - 10%) (Aragon et al, 2017). Several authors have argued that
adaptation to this dietary regime can be beneficial for exercise performance for various
reasons: 1) KB can serve as an alternative fuel for peripheral tissue such as brain and
muscle (Robinson and Williamson, 1980; Stubbs et al., 2017), so potentially it can
improve both physical and cognitive performance during exercise. 2) KB are more
efficient energetically, since the free energy of ATP hydrolysis for ketones is greater than
CHO (Veech, 2004; Evans et al., 2017). 3) KB can attenuate proteolysis in skeletal
muscle, something that might improve recovery from exercise (Robinson and
Williamson, 1980; Evans et al., 2017; Vandoorne et al., 2017). However, a major
limitation to the KD is that long-term adherence to such a restrictive diet has been
reported to be very low (Gibson et al., 2015). Moreover, the micronutrient content of
these diets can be as low as 20% of the dietary reference intakes (Zupec-Kania and
Zupanc, 2008), something that could become problematic for athletes over time.
Despite these potential advantages of KD vs high CHO consumption, several
investigations where individuals adhered to the KD for a period of 4-12 wk have shown
equivocal results relative to exercise performance improvements (Hawley and Leckey,
2015; McSwiney et al., 2018; Burke, 2021). Some researchers argue that this is because
athletes compete at CHO dependent intensities (Hawley and Leckey, 2015), so anything
that affects CHO metabolism adversely would have a negative effect on exercise
performance. For instance, KD have been shown to impair rates of muscle glycogenolysis
and energy flux, resulting in a reduced capacity for high-intensity ATP regeneration
(Stellingwerff et al., 2006). Furthermore, studies indicate that with the up-regulation of
fat utilization for energy, there is a concomitant reduction in pyruvate dehydrogenase
activity, a regulatory enzyme responsible for CHO metabolism (Stellingwerff et al.,
2006). Therefore, the severe CHO restriction seen with KD might impair performance in
sport disciplines that rely heavily on CHO metabolism, despite the potential CHO sparing
effect of KB. For this reason, oral KB supplementation in combination with a high CHO
intake has emerged as a potential aid for athletic performance (Cox et al., 2016; Evans et
al., 2017). Moreover, KB supplementation has become common in professional cycling
in recent years (Pinckaers et al., 2017), and its potential as an ergogenic aid is gaining
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interest in the scientific community. Several aspects of metabolism have been shown to
improve with KB supplementation (Cox et al., 2016; O’Malley et al., 2017; Poffe et al.,
2019) including improved exercise performance, enhanced cognitive function, and
perhaps even faster recovery after exercise ([details are discussed below] Evans et al.,
2017; Valenzuela et al., 2021).
However, the magnitude of ketosis seems to be an important factor to achieve said
positive outcomes and this is influenced by the type of exogenous ketone supplement
ingested.

2.3 Types of Exogenous Ketones
The most direct way of inducing ketosis is to consume exogenous isolated KB. However,
βHB and AcAc in their free acid form can be unstable, expensive, and ineffective at
producing sustained ketosis (Poff et al., 2020). Therefore, KB need to be buffered with
different electrolytes or bound to other ketogenic precursors to enhance their ability to
induce nutritional ketosis (Poff et al., 2020). In general, exogenous ketone supplements
can be divided into three main categories, ketogenic agents, ketone salts and ketone esters
(Poff et al., 2020). Ketogenic agents do not contain any ketone bodies, but rather are
molecules that can be rapidly metabolized in the liver to form βHB, the main KB
circulating in blood (Poff et al., 2020). A couple of examples seen in the literature are
medium chain triglycerides (MCT) and 1,3 Butanediol (1,3 BD). MCT contain shorter
carbon chains (6 to 12 carbons), thus, can be absorbed directly through hepatic
circulation and can enter the hepatocyte without requiring a transporter (Van Zyl et al.,
1996; Poff et al., 2020; Prins et al., 2020). Once in the mitochondria, they are rapidly
broken down to form acetyl CoA and ultimately KB (Van Zyl et al., 1996; Prins et al.,
2020). This means that they have the potential to induce nutritional ketosis even in the
presence of CHO like any other exogenous ketone supplement. However, caution is
recommended when ingesting MCT as these may cause gastrointestinal (GI) problems
especially if ingested in large amounts, although strategies such as a 1–2-wk adaptation
have been explored to attenuate those symptoms (Thorburn et al., 2006; Poff et al., 2020).
Another common agent used to induce ketosis in humans is 1,3 BD. This organic
compound is classified as a diol or dialcohol (meaning it contains two hydroxyl groups)
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(Poff et al., 2020). 1,3 BD is absorbed passively in the gut (Shivva et al., 2016) and is
transported to the liver where it is converted to βHB (Desrochers et al., 1992; Prins et al.,
2020). As with other ketogenic agents, large doses should be avoided as these may induce
GI distress (Shaw et al., 2019; Prins et al., 2020) and/or symptoms that mimic low level
alcohol intoxication such as nausea, euphoria, and dizziness (Shaw et al., 2019).
Typically, these ketogenic agents are ineffective as they induce only modest increases in
βHB blood concentrations. i.e., 0.5 to 0.8 Mm (Scott et al., 2019; Shaw et al., 2019;
Avgerinos et al., 2020; Poff et al., 2020). The remaining two supplement types, ketone
salts (KS) and esters (KE), contain βHB (Stubbs et al., 2017). KS are the most abundant
type of ketone supplement in the marketplace. They are made of βHB molecules bound to
a mineral ion such as calcium, potassium, or sodium (Poff et al., 2020) that can help
buffer hydrogen ions and increase pH (Stubbs et al., 2017). Usually these contain a
racemic mixture of two isoforms of βHB, L- βHB and D-βHB (Stubbs et al., 2017). This
mixture varies depending on the individual product and some are enriched with D-βHB
(Kackley et al., 2020). This mixture is important because the D-βHB, the primary product
of endogenous ketogenesis, is believed to contribute mainly to ATP regeneration
(Kackley et al., 2020). However, KS supplements induce only modest increases in βHB
blood concentrations (Stubbs et al., 2017; Margolis and O’fallon, 2020; Poff et al., 2020).
Recently, some authors have combined MCT and KS attempting to induce greater βHB
blood concentrations and a more prolonged ketosis state and perhaps mitigating any GI
distress (Kesl et al., 2016; Prins et al., 2020). This might be critical because these two
factors likely determine effectiveness of the supplement (Valenzuela et al., 2020).
The third type of exogenous ketones are KE, first described by Birkhahn et al. (1977).
Recently, these have re-emerged as potential ergogenic/therapeutic agents. KE consist of
a ketone body (βHB or AcAc) bound to a ketogenic precursor (1,3 BD, glycerol) through
one or more ester bonds (Stubs et al., 2017; Poff et al., 2020). Several KE are possible,
and each differ in terms of tolerability and possibly in physiological effects (Poff et al.,
2020). However, the only commercially available type to date are ketone monoesters
(KME) and this is the most widely KE supplement type used in human research
(Valenzuela et al., 2021). Specifically, KME are composed of a D-βHB molecule bound
to 1,3 BD through an ester bond (Stubs et al., 2017; Poff et al., 2020; Valenzuela et al.,
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2021) and appears to induce the most effective nutritional ketosis, displaying βHB
concentrations in blood that can be 2-3-fold greater than studies with either KS or
ketogenic agents (Stubbs et al., 2017). As mentioned, the magnitude of ketosis can be
important in inducing meaningful metabolic changes that can have an impact on
performance. Therefore, KME seems to be the best possible option to study and
understand the impact of EK supplementation on exercise performance.

2.3.1 Effects of Exogenous Ketone Supplementation on Exercise
Performance
As discussed above, exogenous ketone supplementation can induce acute nutritional
ketosis (Stubbs et al., 2017). This can shift fuel use during exercise (Cox et al., 2016;
O’Malley et al., 2017) resulting in performance benefits (Cox et al., 2016). As
demonstrated by Cox et al. (2016) in one of the first investigations evaluating oral ketone
supplementation, KME supplementation not only spared CHO during a 60-min prefatiguing effort in elite cyclists, but also resulted in a 2% performance increase in a
subsequent 30-min time trial. Of course, this improvement in performance is important
considering that typically there is <1% difference in performance time between the 1st
and the 10th rider in elite races (Valenzuela et al., 2021). In agreement with the results
seen by Cox et al. (2016), a few subsequent studies have shown performance
improvements (Poffe et al., 2019; Kackley et al., 2020; Poffe et al., 2021a). However, in
contrast, most studies have either failed to demonstrate performance benefits (Rodger et
al., 2017; Evans and Egan, 2018; Waldman et al., 2018; Dearlove et al., 2019; Evans et
al., 2019; James and Greer, 2019; Scott et al., 2019; Shaw et al., 2019; Poffe et al., 2020;
Prins et al., 2020; Poffe et al., 2021b) or have reported performance decrements (Leckey
et al., 2017; O’Malley et al., 2017). Several recent systematic reviews have concluded
that the overall results are equivocal making a conclusion about performance benefits
impossible at the present time (Margolis and O’fallon, 2020; Valenzuela et al., 2020;
Valenzuela et al., 2021). The main reasons for the discrepancy have been attributed to a
high heterogenicity in factors such as ketone supplement type and dose, which can have
important implications in the magnitude of ketosis achieved. For instance, some studies
have used KE (Cox et al., 2016; Leckey et al., 2017; Evans and Egan, 2018; Dearlove et
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al., 2019; Evans et al., 2019; Poffe et al., 2019; Poffe et al., 2020; Poffe et al., 2021a;
Poffe et al., 2021b ) with doses ranging from 330 – 915 mg·kg body mass−1, while others
have used KS (Rodger et al., 2017; O’Malley et al., 2017; Waldman et al., 2018; James
and Greer, 2019; Prins et al., 2020; Kackley et al., 2020) with doses ranging from 106 –
610 mg·kg body mass−1, or ketogenic agents (Scott et al., 2019; Shaw et al., 2019) with
doses ranging from 350 – 500 mg·kg body mass−1. At the time Cox et al. (2016)
conducted the first investigation, KE supplements were not commercially available (only
KS), so only laboratory groups that had the ability to synthesize their own KE were able
to use them in their investigations. Of course, this added to the discrepancies seen in the
literature to date. Another important aspect is that KB pharmacokinetics following a
single dose of ketones have also shown that KB are absorbed at a slower rate in a fed
state, compared to a fasted state (Stubbs et al., 2017) and this differences also need to be
considered. Furthermore, participants in some of these studies have been fed large doses
that were reported to cause GI distress (Leckey et al., 2017; Shaw et al., 2019) and that
aspect alone has been attributed to be responsible at least partially for the lack of benefits
(or even detriments) seen, as it is hard for an athlete to perform while having those
symptoms. Moreover, the tests used to assess performance have differed as well. For
example, some authors have used a best effort time trial (distance or time) while others
have implemented a time to exhaustion test. It is well accepted that best effort time trials
are better predictors of performance as they replicate the demands of competitions while
time to exhaustion tests are often done at submaximal intensities and fixed workloads, so
the interpretation of their results is more limited. In addition, different modes of exercise
such as running or cycling have been used, and perhaps the small sample sizes (50% of
studies used 10 or less participants) are all factors that contribute to these discrepancies
(Margolis and O’fallon, 2020; Valenzuela et al., 2020; Valenzuela et al., 2021). Finally,
as mentioned previously, KE supplementation has been proposed to enhance physical and
cognitive performance as well as post-exercise recovery. Therefore, all the available
evidence regarding each of these aspects of performance is discussed below.
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2.3.2 Exogenous Ketones and Physical Performance
Most studies assessing the effectiveness of acute ketone supplementation to date have
measured some outcome of physical performance. As mentioned, the first study by Cox
et al. (2016) was intriguing as it found an ~2% performance increase in elite cyclists after
ingesting KME, however, only a few subsequent studies have been able to show
improvements in performance (Poffe et al., 2019; Kackley et al., 2020; Poffe et al.,
2021a). For instance, Poffe et al. (2019) had participants train 6 times a wk for 3 wk,
consuming either KME or an isoenergetic drink containing MCT after each training
session. They measured power output (PO) in the last 30-min of a 2-h standardized
endurance session pre- and post intervention and found that PO was 15% greater in the
group that consumed KME. Further, Kackley et al. (2020) found that a KS supplement
containing caffeine and amino acids was effective at improving time to exhaustion during
a staged cycle ergometer test in both Keto-Naïve and in Keto-Adapted participants. Yet,
the majority of studies with ketone supplementation to date have shown no changes in
performance (Rodger et al., 2017; Evans and Egan, 2018; Waldman et al., 2018;
Dearlove et al., 2019; Evans et al., 2019; James and Greer, 2019; Scott et al., 2019; Shaw
et al., 2019; Poffe et al., 2020; Prins et al., 2020; Poffe et al., 2021b) and a couple of
investigations even showed detriments in performance (Leckey et al., 2017; O’Malley et
al., 2017). In the Leckey et al. (2017) study, professional cyclists completed a 31.2 km
time trial after consuming ~18g of a ketone diester drink. A ~2% performance decrement
was reported, although the authors attributed this decrement in performance to gut
disturbances reported by most participants (Leckey et al., 2017). In another study
(O’Malley et al., 2017), healthy recreationally active participants had 7% lower PO
during a 150 kJ time trial (~10-12-min effort) following 15-min of a staged steady state
exercise bout after consuming KS vs a non-caloric placebo.
In an attempt to explain these conflicting data, some authors have suggested that the
magnitude of ketosis (1 -2 mM) is important with respect to potential ergogenic effects
(Margolis and O’fallon, 2020; Valenzuela et al., 2020; Valenzuela et al., 2021). For
instance, in the study by Cox et al. (2016), a KME supplement was used resulting in a
blood ketone concentration of ~3 mM whereas in the two studies where detriments were
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reported, a ketone diester (Leckey et al., 2017) and a KS supplement (O’Malley et al.,
2017) were used, and blood KB concentrations were only ~0.8 mM. In general, KS have
been shown to induce a lower level of ketosis compared to KE (Stubbs et al., 2017) and,
therefore, are less likely to show any positive performance effects (O’Malley et al., 2017;
Rodger et al., 2017; James and Greer, 2019; Waldman et al., 2018; Prins et al., 2020). A
recent metanalysis concluded that KS do not enhance exercise performance (Valenzuela
et al., 2020), and suggested that research should focus on using ketone monoesters
(KME) because they appear to induce sufficient ketosis to cause metabolic changes
(Margolis and O’fallon, 2020). Future study should attempt to elucidate the underlying
mechanisms responsible for any exercise performance changes. Impaired CHO
metabolism has been reported after adopting a KD even if ingestion of CHO returns to
adequate amounts prior to the performance (Burke et al., 2020), which occurs because of
a reduction in pyruvate dehydrogenase activity (PDH), a key regulatory enzyme
responsible for CHO metabolism (Stellingwerff et al., 2006). Although a CHO-sparing
effect has been reported with KME supplementation, it is important to elucidate if this
CHO-sparing effect of ketones could be an actual impairment on CHO metabolism due to
a downregulation in PDH activity as seen with the KD, something that indeed would be
contraindicated for exercise performance at high intensities. In addition, some studies
have shown that ingestion of KME can lower blood pH by ~0.05–0.10 U at rest (Stubbs
et al., 2017) and during submaximal exercise (Dearlove et al., 2019). This could impair
high intensity exercise performance because metabolic acidosis has been shown to impair
rates of glycolysis, the predominant metabolic pathway during high intensity exercise.
Interestingly, Poffe et al. (2021a) tried to address this problem by giving participants
bicarbonate. They compared exercise performance with KME, KME + bicarbonate, or
bicarbonate alone and found that co-ingestion of KME and bicarbonate improved mean
power output during a 15-min time trial at the end of a 3-h cycling race by ~5%
compared to the other conditions. However, the same group (Poffe et al., 2021b) also
found that when ketosis (~3-5mM) was present during a 30-min time trial, there were no
differences in performance independent of bicarbonate use. Clearly, more work needs to
be done to elucidate the effects of ketone supplementation on exercise performance.
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2.3.3 Exogenous Ketones and Cognitive Performance
Another possible benefit of ketone supplementation during exercise is enhanced cognitive
performance (Valenzuela et al., 2021). This could be important, especially late in events
when CHO availability is low, because split-second decisions could influence the
outcome of an event. It is known that KB can cross the blood brain barrier through
monocarboxylate-mediated transport (Evans et al., 2017), and serve as an alternative fuel
for the brain in periods of low glucose availability or energy crisis. In fact, KB can supply
over 60% of the metabolic energy needs of the brain (Cahill Jr, 1970), and this ability to
act as an alternative fuel, i.e., reduce glucose reliance, could help enhance cognitive
performance (Evans et al., 2017; Valenzuela et al., 2021). In addition, KB can increase
the expression of the protein Brain Derived Neurotropic Factor (BDNF), an important
molecule for brain plasticity and regulation of cognitive function (Marosi et al., 2016;
Sleiman et al., 2016). Specifically, βHB is believed to inhibit histone deacetylases,
enzymes that in turn inhibit the production of BDNF in the brain (Sleiman et al., 2016).
Moreover, KB can induce increases in BDNF even when glucose supply is adequate (Hu
et al., 2018), suggesting that exogenous ketone supplementation might improve cognitive
function or attenuate cognitive impairment during prolonged exercise, regardless of
chronic diet composition or macronutrient intake. To date, few studies have evaluated the
efficacy of exogenous ketone supplements on cognitive function during exercise (Evans
and Egan, 2018; Waldman et al., 2018; Evans et al., 2019; Prins et al., 2020; Waldman et
al., 2020). Further, the majority of these studies have measured cognitive function before
and after an exercise intervention (Evans and Egan, 2018; Waldman et al., 2018; Evans et
al., 2019; Prins et al., 2020). For instance, Evans and Egan (2018) were able to
demonstrate that supplementing with KME + CHO before and during a ~90-min
Loughborough intermittent shuttle test (5x15-min intermittent exercise at varying
intensities to simulate soccer play + 15-min time to exhaustion run) reduced the number
of incorrect responses during a cognitive test administered after exercise, when compared
to CHO alone. Similarly, Prins et al. (2020) showed that supplementing with KS + MCT,
an approach that can induce greater βHB blood concentrations and a more sustained
ketotic state, displayed faster response time accuracy prior to a 5k time trial when
compared to a non-caloric placebo or KS alone. However, other studies have failed to
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show improvements in cognitive function after exercise. For instance, Waldman et al.
(2018) reported that KS did not improve cognitive function after performing 4-15s
Wingate-type exercise interspersed with 4-min active recovery, compared to a noncaloric placebo. Likewise, Evans et al. (2019) observed no benefits of acute KME
supplementation on a multitasking test or on reaction time measured before and after a
10K time trial. Interestingly, neural activation associated with exercise rapidly returns to
baseline following the cessation of exercise (Dietrich and Sparling, 2004), therefore, the
time at which these cognitive tasks are administered becomes crucial. Lambourne and
Tomporowski (2010) observed that there were differences in cognitive function when
tests were done during exercise, compared to after exercise (under no supplementation).
Specifically, when cognitive function was measured during exercise it led to impairments
whereas small improvements were seen when it was measured after exercise. These small
methodological differences could, at least in part, explain the discrepancies seen in the
literature. There has only been one study assessing the effects of ketone ingestion on
cognitive function during exercise (Waldman et al., 2020). In this study Waldman et al.
(2020), measured cognitive performance during exercise using a dual stress challenge
(DSC) in an attempt to replicate the cognitive demands seen in high-stress occupations.
Briefly, participants performed a 30-min steady state exercise session (at 60% V̇O2 peak)
while performing two cognitive tests during the last 20 min of exercise. The authors
reported no changes in cognitive function when comparing a KS supplement to a noncaloric placebo. These studies indicate that the effects of exogenous ketone
supplementation on cognitive function during exercise are mixed so clearly more study is
necessary before any conclusion regarding the effectiveness of ketone supplementation
on cognitive performance in sports is possible.

2.3.4 Exogenous Ketones and Post-Exercise Recovery
Recovery is another important aspect of performance that takes on more relevance in
multistage events like the Tour de France or competitive team sports leagues and
tournaments where games can occur with little recovery time like the FIFA World cup.
Ketone + CHO supplementation has been proposed to improve recovery after exercise,
which could directly improve performance on a subsequent day (Valenzuela et al., 2021).
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Several mechanisms suggested to explain this potential ergogenic effect are an increase in
glycogen replenishment (Evans et al., 2017; Holdsworth et al., 2017; Takahashi et al.,
2019) and/or a decrease in protein oxidation (Evans et al., 2017), something that could
favour muscle repair. For example, Takahashi et al. (2019) exposed mice to swimming
exercise for 60-min and subsequently isolated epitrochlearis muscle. Using an in vitro
experimental model, they incubated the isolated muscle with glucose and insulin
concentrations set at values representing those recommended in humans for maximal
skeletal muscle glycogen recovery (1.2 -1.5 g·kg body mass−1·h−1) and the only
difference was the presence or absence of βHB, which was set at 1, 2, or 4mM when
present. The results demonstrated that glycogen replenishment was greater in the
presence of βHB at concentrations of 2 and 4mM, with 4mM displaying greater glycogen
content. Interestingly, early during incubation, βHB activated the proteins of the insulinsignaling cascade, while downregulating AMPK, changes that resulted in non-AMPKmediated translocation of GLUT4 and a downregulation of glycogenolysis. These
alterations may have contributed to the greater glycogen content in the βHB trials after
120-min, as reported by the authors (Takahashi et al., 2019). AMP-activated protein
kinase (AMPK) is known to stimulate the translocation of glucose transporter 4 (GLUT4)
(Fisher et al., 2002), and increase the rate of glycogenolysis (Hunter et al., 2011) while
decreasing glycogen synthesis, in an attempt to restore muscle energy balance.
Unfortunately, only a few investigations assessing the effect of ketone supplementation
and recovery have been conducted in humans (Holdsworth et al., 2017; Vandoorne et al.,
2017; Poffe et al., 2019). Holdsworth et al. (2017) investigated glycogen repletion in
humans using a hyperglycemic clamp to maintain glucose concentrations at ~ 10mM
throughout the experiment and reported that after glycogen depleting exercise, a glucose
clamp + KME supplementation increased glycogen content by 50% after two h,
compared to a glucose clamp alone. Although exercise performance outcomes were not
assessed in this study, this difference in glycogen content would be expected to have a
significant impact on many sport disciplines, as often athletes compete at CHO dependent
intensities (Hawley and Leckey, 2015). However, Vandoorne et al. (2017) explored the
same issue in humans and found conflicting results. In this study, participants performed
a bout of intense one-leg glycogen depleting exercise followed by a 5-h recovery period.
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During the recovery time, a protein (PRO)-CHO supplement containing adequate
amounts (1.0 g·kg body mass−1·h−1 of CHO and 0.3 g·kg body mass−1·h−1 of PRO) to
obtain optimal muscle protein (Phillips and Van Loon, 2011) and glycogen synthesis
(Cermak and Van Loon, 2013) was ingested with or without KME. The authors found
that KME + PRO-CHO supplement ingestion increased mTORC1 activation in human
skeletal muscle following exercise, and enhanced leucine-mediated muscle protein
synthesis using a series of in vitro experiments. This may have been because of the
observed downregulation of AMPK early during recovery in the KME trial, which in turn
would help increase activation of mTORC1 since AMPK may inhibit the mTOR pathway
and promote proteolysis (Bolster et al., 2002). Nevertheless, no differences in glycogen
resynthesis between both KME and placebo trials were observed. Interestingly, a recent
study (Poffe et al., 2019) where participants completed a 3-wk intensive training program
designed to induce physiological and perceptual symptoms of overreaching found that,
compared to placebo, chronic (3 wk) post exercise and before sleep KME
supplementation blunted the physiological symptoms of overreaching vs an isoenergetic
MCT. Specifically, KME improved PO during a 30-min time trial performed pre- and
post intervention (Poffe et al., 2019). Sprint performance was reduced for all participants
due to overtraining, but the KME group marked a tendency to prevent glycogen depletion
(resting glycogen content decreased in the control group after 3 wk of training (p<0.05)
but not in the KME group [p= 0.99]), tolerated greater workloads in the last wk of
training and displayed a 15% higher PO during a 30-min time trial at the end of the 3-wk
training period (Poffe et al., 2019). However, these data must be interpreted cautiously
because food intake during the study was ad libitum and based on 2 d food record
estimations both energy and CHO was greater in the KME group (wk 2: energy = 3,598
vs 3,981 kcal/d; wk 3: 3,653 vs 4,199 kcal/d; wk 2: CHO = 1,772 vs 2,067 kcal/d; wk 3:
1,773 vs 2,154 kcal/d) vs the control group. Although intriguing, more research needs to
be done to elucidate the efficacy of ketone supplements to promote recovery and enhance
performance.
In summary, EK supplementation presents as an alternative to reach a state of nutritional
ketosis. This state of nutritional ketosis achieved through supplementation has been
shown to reduce rates of glycolysis, increase KB utilization for ATP regeneration leading
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to a possible CHO-sparing effect, which in turn could benefit exercise performance as
demonstrated initially by Cox et al. (2016). Since the pioneering work of Cox et al.
(2016) other authors proposed that ketones could help improve not only physical
performance but also cognitive performance and post-exercise recovery since KB have
been shown to be an important fuel for the brain with an established neuroprotective role
in non-exercise contexts as well as an important signaling molecule capable of enhancing
the recovery process by increasing glycogen replenishment and reducing proteolysis
(Evans et al., 2017). However, subsequent studies have shown equivocal results, with
some studies reporting increased exercise performance but the majority of other showing
no difference. Unfortunately, the majority of these studies have focused on measuring
physical performance so the evidence regarding cognitive function during exercise or
post-exercise recovery is lacking. Therefore, the purpose of this dissertation was to
confirm possible ergogenic effects of KS supplementation seen in only one study, and
also provide more insight to the short body of evidence evaluating cognitive function
during exercise and post-exercise recovery, using KME supplementation.
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Chapter 3

3

Acute ketone salts-caffeine-taurine-leucine supplementation but not
ketone salts-taurine-leucine, improves endurance cycling performance
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3.1 Abstract
Co-ingestion of ketone salts, caffeine and the amino acids, taurine and leucine has been
shown to improve endurance exercise performance. However, there is no study
comparing this co-ingestion to the same nutrients without caffeine. We assessed whether
ketone salts-caffeine-taurine-leucine (KCT) supplementation was superior to caffeinefree ketone salts-taurine-leucine supplementation (KT), or to an iso-energetic CHO
placebo (PLAC). 13 recreationally active men (177.5±6.1 cm, 75.9±4.6 kg, 23±3 y,
12.0±5.1 % body fat; mean±SD) completed a best effort 20 km cycling time trial
(TT20km), followed 15 min later by a Wingate power cycle test, after supplementing
with either KCT (~7g of βHB, ~ 120mg caffeine, 2.1g leucine, 2.7g taurine), KT (i.e.,
same supplement without caffeine), or iso-energetic PLAC (11g of dextrose). Blood betahydroxybutyrate (βHB) were elevated (p< 0.001) after ingestion of both KCT (0.65±0.12
mM) and KT (0.72±0.31 mM) relative to PLAC (0.06±0.05 mM). Moreover, KCT
improved TT20km performance (37.8±2.38 min), compared to PLAC (39.4±3.33 min; p=
0.003) but not vs KT (38.8±2.87min; p= 0.09). TT20km average PO was greater with
KCT (PO= 181 ± 29 W) vs both KT (171 ± 32 W; p= 0.05) and PLAC (165 ± 35 W; p=
0.001). Peak power output for the Wingate test was also greater for both KCT (1134 ±
137 W; p= 0.03) and KT (1132 ± 128 W; p= 0.04) vs PLAC (1068 ± 127 W). These data
suggest that the observed improved endurance performance effects are likely the result of
the co-ingestion of ketone salts, caffeine and taurine rather than ketones alone.
Keywords: exogenous ketones, ketosis, supplement, endurance exercise performance,
Wingate
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3.2 Introduction
The ketogenic diet is a nutritional strategy characterized by substantial fat (~70 to 80%
energy intake) as well as very low CHO (~5% energy intake). This dietary approach has
received considerable attention over the past few years as a possible intervention to
enhance endurance exercise performance (Volek et al., 2015). The rationale underlying
this approach is that fat represents a virtually unlimited energy source even in lean
individuals (Sansone et al., 2018; Volek et. al., 2015), while the other major muscle fuel,
CHO can be depleted during a single exercise bout (~1-2 h of moderate-high intensity
exercise; Saltin, 1973; Hawley and Leckey, 2015). Moreover, high dietary fat has
significant potential with respect to endurance exercise performance because the resulting
upregulated fat mobilization triggers a substantial increased accumulation of circulating
ketone bodies. This is called nutritional ketosis (Evans et al., 2017) and is characterized
typically by a plasma ketone concentration of ~0.5–3.0 mM, i.e., hyperketonemia
(Gibson and Sainsbury, 2017). Importantly, this metabolic state provides a large supply
of muscle fuel and is very different than ketoacidosis, a life-threatening condition that can
affect diabetics or alcoholics, where the plasma ketone concentration can reach ~10+
mM.
In theory, ketones have at least two metabolic advantages over CHO relative to exercise
performance. First, as mentioned, they provide an almost unlimited source of energy and
second their free energy of ATP hydrolysis is greater than CHO, i.e., ketone bodies are
energetically more efficient vs CHO (Evans et al., 2017). However, despite these
theoretical advantages, adopting to a ketogenic diet does not produce a clear performance
benefit for endurance exercise compared to a high CHO diet (Burke, 2020). Likely, this is
because the associated low CHO intake results in a reduced pyruvate dehydrogenase
activity, a key regulatory enzyme in CHO metabolism (Peters et al., 1998). For most
athletes, this is critical because they compete at intensities that are largely CHOdependent (Burke, 2020).
Given the constant pursuit of athletes to find nutritional strategies to enhance exercise
performance, manufacturers have developed ketone supplements that induce a state of
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mild-modest nutritional ketosis acutely (~1 h). However importantly, this differs from
dietary ketosis because these supplements can allow a state of ketosis to be achieved with
replete glycogen stores. Therefore, supplemental hyperketonemia has the potential to
provide additional muscle fuel (Pinckaers et al., 2017) while sparing CHO. If so, athletic
performance could be enhanced. In support of this possibility, Cox et al. (2016)
demonstrated a reduction in glycogen use and an increase in fat use during endurance
exercise after consuming a ketone ester supplement. In contrast, several subsequent
studies assessing the effectiveness of ketone supplements on endurance performance are
inconsistent (Margolis and O’fallon, 2020). This may be because of differing
experimental methodologies, especially ketone supplement types, and/or dosages used.
Recently, ingestion of a pre-workout supplement containing ketone salts, the amino acids,
taurine and leucine, and caffeine improved high intensity exercise performance (Kackley
et al., 2020). Unfortunately, the investigators used a water placebo which is problematic
here because caffeine is a well-established performance aid (Grgic et al., 2020), even
when consumed at low dosages (Pickering and Kiely, 2019). Further, taurine can also
improve exercise performance (Warnock et al., 2017). Therefore, the purpose of our
study was to determine the endurance exercise performance effects of a ketone saltscaffeine-leucine-taurine drink (KCT) vs both the same drink without caffeine (KT) and
an isoenergetic dextrose placebo (PLAC).

3.3 Methods
Participants
Thirteen healthy, young, recreationally active men volunteered to participate (177.5±6.1
cm, 75.9±4.6 kg, 23±3 y, 12.0±5.1 % body fat). All were involved in exercise/sports
activities at least twice a wk prior to the study. Each completed a health information form
and a physical activity readiness questionnaire (PAR-Q; Thomas et al., 1992) to minimize
any potential contraindications to exercise. Potential experimental risks were explained
fully prior to any testing and the participants provided written, informed consent of the

35

study protocol approved previously by the University of Western Ontario’s Office of
Research Ethics.

Familiarization Session
Prior to the three experimental trials, participants visited the laboratory for a
familiarization session. During this visit, body composition (Bod Pod®) was measured
by densitometry, as described previously (Noreen and Lemon, 2006) and, to minimize
potential experimental learning effects, participants were given an opportunity to practice
the exercise tests (20 km cycling time trial [TT20km] and a 30 sec Wingate power test) to
be used during the experimental treatments.

Experimental Treatments
A double-blind, repeated-measures crossover research design was implemented involving
three experimental treatments, ketone salts (beta-hydroxybutyrate - βHB) with caffeine,
leucine and taurine (KCT [KETO//OS – NAT – charged - ~120mg of caffeine; ~7g βHB,
~2.1g of leucine, ~2.7g of taurine), Pruvit Ventures. Inc, Melissa, TX, USA]), ketone
salts, leucine, taurine without caffeine (KT [KETO//OS – NAT – caffeine free - ~7g
βHB, ~2.1g of leucine, ~2.7g of taurine), Pruvit Ventures. Inc, Melissa, TX, USA]), or
iso-energetic dextrose monohydrate (PLAC, 11 g dextrose). Endurance performance was
evaluated under each treatment using a best effort cycle TT20km followed 15 min later
with a 30 sec maximal Wingate cycle power test. (Figure 3.1; details below).
Each trial was separated by at least one wk and testing occurred during the same time of
the day for each participant (±1 h). To avoid order effects, the first participant was
randomized to treatment order and each subsequent individual had the experimental
treatments rotated systematically. Further, to minimize dietary differences among
treatments, each participant maintained a dietary record of all food/drink intake for the
two d prior to the first experimental session and replicated this intake for the two d
preceding the subsequent trials. Ratings of perceived exertion (RPE; 6-20 scale; Borg
and Noble, 1974) and fingerstick blood samples, assessed for βHB and lactate, were
obtained before, during, and following the exercise tests (Figure 3.1).
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Figure 3.1. Overview of study protocol

Experimental Protocol
Each participant reported to the laboratory 4 h postprandial with limited activity
(drive/use of the elevator to get to the lab) as well as having abstained from strenuous
exercise, caffeine, or alcohol consumption for 24 h. These controls were utilized not only
to standardize conditions among treatments but also to ensure that participants exercised
in a fed state, which is typical for most athletes.
Upon arrival at the laboratory, measures of baseline blood βHB (FreeStyle Precision
Neo®, Abbott Diabetes Care Limited) and blood lactate (Lactate Scout+, EKF
Diagnostics) concentration were obtained from finger stick blood samples. Subsequently,
the experimental drink was provided, and participants were given 30 min of rest to allow
for digestion/absorption of the supplement. All drinks consisted of 500 ml of water mixed
with either KCT, KT, or PLAC. This quantity of ketone salts and the volume of water
used to prepare the beverages were based on the manufacturer’s guidelines. Water was
available ad libitum throughout the first exercise trial and the intake recorded (598±358
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ml) so it could be reproduced during subsequent trials. After 30 min, participants
performed a standardized (10 min) warm up (cycling at 100 watts) and then completed
the best effort TT20km on a Velotron cycle ergometer (Computrainer, RacerMate Inc,
Seattle, WA). Gearing was kept constant and participants were blinded to feedback such
as time, speed, RPM, power output, and heart rate (only distance travelled was provided).
Fifteen min later, the 30 sec Wingate cycle power test was performed. Briefly, following
a 25 sec lead in, where participants gradually increased their cadence to ~150 RPM, the
load (9% of body mass) was engaged, and participants maintained the greatest power
output possible throughout 30 sec. Peak power output, average power output and fatigue
index (rate of drop off over the 30 sec) were determined using an online data acquisition
system (Computrainer, RacerMate Inc, Seattle, WA).

3.4 Statistical Analysis
Statistical analyses were performed using SigmaPlot for Windows (Version 12.0). All
data were tested for normality and a non-parametric test (ANOVA on Ranks Test) was
used wherever a data set was not normally distributed. Blood metabolite concentrations
and rates of perceived exertion were analyzed using a two-way (treatment by time)
repeated measures ANOVA. Performance outcomes were analyzed using a one-way
repeated measures ANOVA. Post hoc Tukey’s HSD testing was used wherever
significant main or interaction effects were found. Significance was set at p ≤ 0.05. Data
are presented as means ± SD.

3.5 Results
Blood Ketones (βHB)
There was a main effect of time (p< 0.001), a main effect of treatment (p< 0.001), as well
as a significant interaction (p< 0.001) for blood βHB concentration. Pairwise
comparisons indicated that blood βHB were significantly greater (p<0.001) for both KCT
and KT groups compared to PLAC at 30 min post treatment ingestion, as well as before,
during, and after the TT20km (Figure 3.2). The KCT post TT20km βHB concentration was
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also significantly greater (p= 0.04) vs KT. Furthermore, KCT βHB concentration before
the Wingate test was greater vs both KT (p= 0.01) and PLAC (p< 0.001).

Figure 3.2. Blood βHB concentration. Values are means ± SD. WU= warm-up; KCT= ketone
salts-caffeine-taurine-leucine supplement; KT= ketone salts-taurine-leucine supplement; PLAC=
iso-energetic CHO placebo. *Significantly different versus PLAC. # Significantly different versus
both KT and PLAC.

Blood Lactate
There was a main effect of time (p< 0.001), a main effect of treatment (p= 0.01), as well
as a significant interaction (p= 0.02) for blood lactate concentration. Pairwise
comparisons showed that blood lactate was significantly greater during the TT20km for
KCT compared to both KT (p= 0.03) and PLAC (p= 0.02), as well as immediately after
the Wingate test (KCT vs KT vs PLAC; p< 0.001) (Figure 3.3). Additionally, the blood
lactate concentration right after the TT20km was significantly greater (p= 0.01) for KCT vs
PLAC, but not vs KT (p= 0.20).
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Figure 3.3. Blood lactate concentration. Values are means ± SD. WU= warm-up; KCT= ketone
salts-caffeine-taurine-leucine supplement; KT= ketone salts-taurine-leucine supplement; PLAC=
iso-energetic CHO placebo. *Significantly different versus PLAC. # Significantly different versus
both KT and PLAC.

Ratings of Perceived Exertion (RPE)
A main effect of time (p< 0.001) was detected for RPE (Table 1). As expected, average
RPE increased for all treatments as the exercise session progressed. No treatment effect
(p= 0.92) nor treatment x time interactions (p= 0.65) were observed.

Measures of Exercise Performance
20 Km Time Trial
There were significant differences in both, time to complete best effort TT20km (p= 0.004)
and in average TT20km power output (p= 0.002). Post hoc Tukey’s HSD testing revealed
that time to complete TT20km was significantly improved (p=0.003) in the KCT trial
(37.8±2.28 min) compared to the PLAC (39.4±3.33 min) trial (Figure 3.4). The observed
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KCT vs KT differences (38.8±2.87 min; p= 0.09) did not attain significance (Figure 3.4).
Moreover, average TT20km power output in the KCT trial was significantly greater (181 ±
29 W) than both KT (171 ± 32 W; p= 0.05) and PLAC (165 ± 35 W; p= 0.001) trials
(Table 3.1).

Figure 3.4. Time to complete TT20 km. Values are means ± SD. KCT= ketone salts-caffeinetaurine-leucine supplement; KT= ketone salts-taurine-leucine supplement; PLAC= iso-energetic
CHO placebo. *Significantly different versus PLAC. Lines represent individual responses.

Wingate Test
There were significant differences in Wingate peak power output (p= 0.02). Post hoc
Tukey’s HSD testing revealed that peak power output was significantly greater for both
KCT (p= 0.03) and KT (p= 0.04) compared to PLAC (Table 3.1). Further, both average
Wingate power output (p= 0.08) and the fatigue index (p= 0.09) approached significance
for both ketone treatments vs PLAC.
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Table 3.1. Performance outcome measures
KCT

TT20Km
Avg PO (W)
Wingate
Avg PO (W)
Peak PO (W)
Fatigue index
(W/S)

KT

PLAC

One-way RM ANOVA
P-value Post hoc Tukey’s HSD test
KCT vs
PLAC

KCT vs KT

KT vs
PLAC

181 ± 29a,b

171 ± 32

165 ± 35

0.002

0.001

0.05

0.27

651 ± 70
1134 ± 137b

646 ± 71
1132 ± 128b

634 ± 71
1068 ± 127

0.08
0.02

0.03

0.99

0.04

25.3 ± 5.7

25.1 ± 4.9

23.5 ± 4.6

0.09

RPE
Pre TT20Km
During TT20Km
Post TT20Km
Post Wingate

Two-way RM ANOVA

8.8 ± 2.1
9.1 ± 2.0
9.2 ± 2.1
Time Effect
p < 0.001
14.2 ± 1.2
13.8 ± 1.4
14.0 ± 1.2
Treatment Effect
p = 0.92
16.8 ± 2.0
16.8 ± 1.3
16.6 ± 2.1
Interaction Effect
p = 0.65
18.9 ± 1.2
18.8 ± 1.5
18.7 ± 1.2
Values are means ± SD. Comparison for Time trial and Wingate power test were done using one-way
repeated measures ANOVA. RPE data was analyzed using two-way repeated measures ANOVA. Post hoc
Tukey’s HSD testing was used to figure out differences between treatments. PO= power output, W= watts,
rpm= revolutions per minute, TT20Km = 20 km best effort time trial.
a
indicates significant difference from KT group
b
indicates significant difference from PLAC group

3.6 Discussion
The aim of the present study was to assess the effectiveness of acute supplementation
with ketone salts-taurine-leucine with (KCT) and without caffeine (KT) vs isoenergetic
PLAC (dextrose) on endurance exercise performance. Our results revealed that the time
to complete the best effort TT20km was improved with KCT supplementation compared to
PLAC. Although, the TT20km time differences between KCT and KT (p= 0.30) did not
attain significance, the observed significant average TT20km power output was greater (p=
0.05) with KCT vs KT suggesting that the added caffeine was effective. In addition, peak
power output during the Wingate test was greater in both KCT and KT compared to
PLAC, while average Wingate power output also favored both ketone groups but not
significantly (p= 0.08).
Previous studies evaluating the effects of ketone supplements on exercise performance
have been inconsistent, with some studies showing positive effects (Kackley et al., 2020;
Cox et al., 2016; Poffe et al., 2019), some others negative effects (Leckey et al., 2017;
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O’Malley et al., 2017), while others observed no differences (Rodger et al., 2017; Evans
et al., 2019; James and Greer, 2019; Waldman et al., 2018). These conflicting results may
be caused by differing methodological practices amongst studies (Margolis and O’fallon,
2020). For instance, previous investigations have used different participant populations,
ketone supplement types and performance tests, making definitive recommendations
regarding ketone supplementation and exercise performance challenging.
A recent publication reported that vs a water placebo, a pre-workout supplement
containing caffeine, ketone salts as well as the amino acids, taurine and leucine extended
time to fatigue during high intensity cycling exercise in both keto-adapted and those
ingesting a normal diet (Kackley et al., 2020). Caffeine is a well-established ergogenic
substance (Grgic et al., 2020), even if ingested in small amounts (Pickering and Kyely,
2019), therefore, the improved performance seen in the study by Kackley et al. (2020)
could have been due to the caffeine as the same supplement without caffeine was not
evaluated.
In the present study, the comparison between caffeinated and caffeine-free ketone
supplementation was made. The ketone supplements used in this study differed only with
respect to the presence of caffeine. When compared to PLAC, our TT20km results indicate
that caffeine was critical. This indicates that the Kackley et al. (2020) performance
enhancement may have been due to the caffeine not the ketones. Further, the observed
lack of a significant TT20km improvement in our KT trial vs PLAC suggests that ketone
salt supplements have little effect on this type of endurance exercise performance. This
conclusion is consistent with several previous studies with ketone supplementation
(Rodger et al., 2017; O’Malley et al., 2017; Waldman et al., 2018; James and Greer,
2019) and suggests that the ergogenic effects observed with our KCT, at least for the
TT20km, were likely due to the caffeine content.
In contrast, our observed 15 min post TT20km, 30 second Wingate test results cannot be
attributed to caffeine as both ketone supplements enhanced performance. For example,
both KCT and KT trials resulted in greater (p= 0.03 and p= 0.04) Wingate peak power
output vs PLAC. Moreover, average power output and the fatigue index, which are
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arguably more representative of anaerobic performance, approached statistical
significance (p= 0.08 and p= 0.09, respectively) with both KCT and KT trials vs PLAC.
While the explanation here is unclear it might involve the amino acid taurine as it was
present in both ketone supplements and has been shown to enhance Wingate performance
previously (Warnock et al., 2017). More study is needed to determine the magnitude of
any performance effects of taurine.
Previously, blood lactate concentration has been shown to be lower during exercise after
ingestion of a ketone ester supplement (Cox et al., 2016; Leckey et al., 2017). Of course,
lactate is produced during the metabolism of CHO, and therefore, the lower
concentrations seen with hyperketonemia may indicate a possible CHO sparing effect,
something that could be advantageous for endurance events (Cox et al., 2016). Our blood
lactate data were greater consistently with KCT perhaps the result of a greater reliance on
CHO as a fuel during either or both exercise performance tests with KCT. Interestingly,
the improved performance seen in the KCT trial was not accompanied by an increased
perception of effort, as RPE was very similar across all treatments.
Finally, it has been suggested that a minimum blood βHB concentration of >1mM is
important to elicit positive effects of ketone supplementation (Margolis and O’fallon,
2020). While both ketone supplements we used elevated blood βHB (6-7 fold), neither
attained this concentration (peaked at 0.7 mM) perhaps because we used the fed state
which enhanced ecological validity but could have slowed supplement absorption,
reducing their effectiveness (Stubbs et al., 2017).
In summary, ingestion of KCT and KT elevated blood βHB concentration substantially
but the absolute concentration was <1mM. KCT improved performance on a best effort
TT20km when compared to both KT and PLAC. Further, both KCT and KT improved
Wingate peak power output. These data suggest both caffeine and taurine contribute to
these performance benefits and that CHO sparing might be involved. With these data, it is
difficult to separate the role of ketone salts on performance due to the presence of several
components in the supplement studied. Further, study is needed with single ingredients to
elucidate any individual or synergistic effects of the ketone salts-caffeine-taurine-leucine
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supplement combination but at this time it appears that ketone supplementation alone is
unlikely to enhance this type of endurance performance.
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Chapter 4
4

Ketone ester and carbohydrate supplementation does not improve
subsequent time trial performance after glycogen lowering exercise.
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4.1 Abstract
Relative to CHO alone, exogenous ketones and CHO supplementation have been shown
to display greater muscle glycogen content after a 2-h recovery period following
glycogen depleting exercise. However, whether this strategy improves subsequent
performance is still unknown. We assessed the efficacy of ketone monoester (KME) and
CHO supplementation on 20 km (TT20km) and 5 km (TT5km) best effort time trials after
a 4-h recovery period following glycogen lowering exercise. 9 endurance trained men
(175.6 ± 5.3 cm, 72.9 ± 7.7 kg, 28 ± 5 y, 12.2 ± 3.2 % body fat, V̇O2max= 56 ± 6 ml· kg
BM−1·min−1; mean±SD) completed a glycogen lowering exercise session, followed by a
4-h recovery period and subsequent TT20km and TT5km. During the first 2 h of
recovery, participants ingested either KME and CHO (KME + CHO) or an iso-energetic
placebo and CHO (PLAC + CHO). Blood metabolites during recovery and performance
during subsequent time trials were measured. KME + CHO displayed greater blood betahydroxybutyrate (βHB) concentration (ranged from 2.7mM at 30-min to 1.2 mM at 120min; p< 0.001) during the 2-h feeding period and lower blood glucose concentration at 30
(5.8±0.6 vs 7.1±0.8 mM, p= 0.003) and 60 (6.1±1.2 vs 7.2±2.3 mM, p= 0.009) min of the
2-h feeding period. However, no differences in power output (TT20km=174±22 vs
169±26 W; p=0.427; TT5km=182±32 vs 186±41 W; p=0.524) nor time to complete the
time trials (TT20km=38.4±2.25 vs 38.9±1.56 min; p=0.420; TT5km=9.5±0.65 vs
9.5±0.88 min; p=0.884) were seen compared to PLAC + CHO. These data suggest that
metabolic changes induced by KME + CHO are not sufficient to elicit any potential
benefits in subsequent time trial performance. More study is warranted to assess fully the
potential benefits of KME supplementation for athletes during exercise recovery.
Keywords: exogenous ketones, ketosis, glycogen repletion, exercise recovery, insulin.
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4.2 Introduction
CHO is considered an important fuel for exercise because the onset of fatigue during
prolonged exercise performance at moderate to high intensities is associated with
glycogen depletion (Jeukendrup, 2004; Cermak and Van Loon, 2013; Hawley and
Leckey, 2015), which occurs typically within ~1-2 h (Saltin, 1973; Hawley and Leckey,
2015). Therefore, greater initial muscle glycogen content has been shown to correlate
with better performance not only in intense, intermittent sports (Saltin, 1973; Krustup et
al., 2006) but also in prolonged endurance efforts (Coyle et al, 1986). As such, repletion
of CHO stores immediately after exercise is an important factor that could determine
performance in subsequent events, especially if these events occur within 24 h (Cermak
and Van Loon, 2013). Dose-response studies have determined that CHO ingestion of
~1.2 g·kg-1·h-1 is the appropriate acute recovery dose to optimize glycogen repletion with
no apparent benefit at greater doses (Cermak and Van Loon, 2013). Protein (PRO) in
combination with CHO has also been proposed to enhance glycogen resynthesis when 1
part PRO is provided with ~4 parts CHO (Berardi et al., 2008; Upshaw et al., 2016). Both
strategies have resulted in better exercise performance a few h after a glycogen lowering
exercise bout (Berardi et al., 2008; Cermak and Van Loon, 2013; Upshaw et al., 2016).
Ketone bodies (KB) are water-soluble lipid derived molecules that have been recognized
as important because they provide alternative fuel during fasting or exercise, and because
they serve as a critical signaling metabolite (Newman and Verdin, 2014). Recently,
exogenous ketone supplements have emerged as an effective way to elevate circulating
KB that may enhance post-exercise recovery by increasing muscle glycogen content via
an insulinotropic response (Holdsworth et al., 2017; Valenzuela et al., 2021) and/or by
enhancing protein synthesis (Vandoorne et al., 2017). Nevertheless, evidence in this area
of research is scarce and controversial. In animal studies, exogenous KB have been
shown to result in enhanced glycogen content when combined with CHO (Maizels et al.,
1977; Laughlin et al., 1994; Takahashi et al., 2019). In humans, the first to explore this
issue was Holdsworth et al. (2017). These authors demonstrated that glycogen repletion
was 50% greater when glucose and a ketone monoester (KME) were taken together,
compared to glucose alone. However, in this study they used a hyperglycemic clamp to
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maintain glucose concentrations at ~10mM throughout the experiment, something that is
impractical for athletes. The only other study that evaluated this issue in humans was
conducted by Vandoorne et al. (2017). In their study, participants were given a drink
containing 1.0 g·kg-1·h-1 CHO and 0.3 g·kg-1·h-1of PRO while consuming a KME or
placebo. No differences in glycogen repletion were observed but the activation of
mTORC1, a molecular pathway responsible for protein synthesis was increased.
Unfortunately, exercise performance was not assessed in any of these studies, so it is
unclear whether or not the positive outcomes observed with concomitant consumption of
a KME and CHO is sufficient to enhance subsequent exercise performance. Therefore,
the purpose of this study was to assess the efficacy of KME + CHO supplementation on
20 km and 5 km best effort time trials completed after a 4-h recovery period following
glycogen lowering exercise.

4.3 Methods
Participants
A total of 13 healthy, endurance trained men were recruited but three participants did not
complete the entire experimental protocol due to laboratory closures and restrictions
during the COVID-19 pandemic. Another was injured (activities outside of the lab)
before completing the study. These four participants were excluded from data analysis
and the remaining 9 were included in the study (Table 1). All were involved in some type
of endurance training at least 3 d per wk for 6 mo or more prior to the study. Each
completed a physical activity readiness questionnaire (PAR-Q+ - Thomas et al., 1992)
and a health information form to minimize any potential contraindications to exercise. All
potential risks were explained fully prior to any testing, and the participants provided
written, informed consent of the study protocol approved previously by the Western
University Office of Research Ethics.
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Table 4.1. Participant Characteristics and Dietary Intake (n=9)
Characteristics
Height, cm
Body mass, kg
Age, y
Body fata, %
Ẇmaxb
V̇O2maxc, ml·kg-1·min-1
Intakesd
Energy, kcal·kg-1·d-1
Carbohydrate, g·kg-1·d-1
Protein, g·kg-1·d-1
Fat, g·kg-1·d-1

Value
175.6 ± 5.3
72.9 ± 7.7
28.0 ± 5.0
12.2 ± 3.2
314.6 ± 42.3
56 ± 6
32.2 ± 3.5
3.5 ± 0.4
1.3 ± 0.3
1.6 ± 0.4

Values are means ± SD, n=9. Ẇmax, maximum cycle wattage; V̇O2max, maximum oxygen
consumption.
a
Body fat was measured using a Bod Pod® (COSMED).
b
Maximum wattage was measured using a ramp incremental test on a Velotron bicycle (Racer Mate,
Seattle, WA).
c
Maximum oxygen consumption was measured using breath-by-breath gas analysis during the
incremental cycle max test (Vmax Legacy, SensorMedics, Yorba Linda, CA).
d
Energy intake and macronutrient breakdown were based on a 2-day dietary record analysis.

General Study Design
A double blind, randomized, crossover research design was implemented involving two
preliminary and two experimental sessions. The preliminary sessions were conducted
before any experimental sessions began to collect baseline data as well as to acclimate
participants to all the procedures implemented during the experimental sessions. These
preliminary sessions were separated by at least two d and the second session was
completed at least five d before starting the experiment. There were two experimental
sessions, separated by at least one wk and conducted at the same time of the d. These
experimental sessions were rotated systematically to prevent order effects. Further, to
minimize food intake differences across treatments, participants recorded their entire
food/drink intake for the d preceding and the d of the first experimental session and
replicated this intake for their second trial. Experimental sessions were comprised of a
glycogen lowering exercise protocol followed by a 4h recovery period where participants
received either a KME drink (TdeltaS Ltd, Thame Oxfordshire, United Kingdom) + CHO
(Dextrose monohydrate) or isoenergetic CHO alone (PLAC - details below).
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Subsequently, participants performed a 20 km (TT20km) and 5 km (TT5km) best effort time
trials to assess the impact of this recovery nutrition on performance (Figure 4.1).

Figure 4.1. Overview of study protocol

Preliminary Sessions
Participants visited the laboratory on two separate occasions prior to any experiments for
familiarization sessions. During the initial visit, body composition (Bod Pod®,
COSMED, Concord, CA), and an incremental cycle exercise test to volitional fatigue
were conducted to determine percent body fat as well as peak cycle power output
(Ẇmax) and V̇O2max, respectively. Briefly, body density was measured using the
BodPod® and body composition was estimated from body density via the Siri (Siri,
1961) equation. Moreover, V̇O2max and Ẇmax were determined with an incremental
ramp protocol on a Velotron cycle ergometer (Racer Mate, Seattle, WA). Briefly,
participants engaged in a 2-min warm up at 100Ẇ followed by an increase of 1Ẇ every 3
sec until volitional fatigue. The greatest wattage was recorded (Ẇmax). Expired gases
were collected via a breath-by-breath collection system (Sensormedics Vmax 29, Yorba
Linda, CA), previously calibrated according to manufacturer’s guidelines using known
gas volumes and composition. The greatest value achieved over a 20-sec collection
period was considered max whenever a plateau in V̇O2 occurred (<50% of the expected
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increase in oxygen uptake for the increased workload) or when two of the following three
criterion measures were attained (±10 bpm of age predicted maximum HR, RER >1.15
[RER = volume of CO2 produced/volume of O2 consumed] or volitional fatigue). Heart
rate (HR) was monitored throughout the test (Polar RST200TM, Polar Electro Inc.,
Lachine, Quebec).
At least 48 h following the first visit, participants visited the lab a second time to
familiarize themselves with the TT20km and TT5km to be used during the experimental
sessions. This was done to minimize potential learning effects.

Experimental Sessions
Participants reported to the laboratory at 0800h following a 12h overnight fast, with
limited activity (drive/use of the elevator to get to the laboratory) and having abstained
from strenuous exercise, caffeine, or alcohol consumption for 24 h. Upon arrival, and
after verbal confirmation of a fasted state, participants performed a glycogen lowering
exercise bout on a Velotron cycle ergometer. Briefly, the protocol began with a 10-min
warm-up at a workload of 50% Ẇmax. Thereafter, participants engaged in an intermittent
exercise protocol that involved cycling in 1-min intervals alternating between workloads
of 90% (high intensity effort) and 50% (recovery) of Ẇmax, respectively. When
participants fatigued (inability to maintain cadence at 60 pedal rev/min during the high
intensity effort) the greater workload was dropped by 10% of Ẇmax. Subsequent
reductions in workload to 80%, 70%, etc. were done progressively until participants
completed 60% of Ẇmax as the greater workload or could not maintain cadence at 60
rev/min. The recovery workload was 50% Ẇmax throughout. The duration of the
protocol was 56 ± 15.6 min. Water during the glycogen lowering exercise was provided
ad libitum and the amount was recorded (640.4 ± 237.2 ml) and replicated in the
subsequent experimental trial.
Following the glycogen lowering exercise, CHO recovery drinks and the corresponding
treatment were provided. The KME supplement contained 25g of ketone esters, providing
a dose of ~0.35 g·kg BM-1. Blood samples were collected for the first 2 h of a 4-h
recovery period. Specifically, capillary blood samples to measure glucose and beta-
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hydroxybutyrate (βHB) (FreeStyle Precision Neo®, Abbott Diabetes Care Limited), were
obtained immediately after the glycogen lowering exercise and every 30 min during the
first 2 h of recovery using a fingerstick method (Figure 4.1). Venous blood samples (~5
ml) to measure serum insulin concentration were collected from an antecubital vein
immediately after the glycogen lowering exercise and each h for the first 2h of recovery,
using a 21-gauge vacutainer needle and serum separator tubes containing a clot activator.
The samples were allowed to clot at room temperature for 30-min and then centrifuged at
3000rpm for 10-min at 4°C (Allegra 21R; Beckman Coulter, Mississauga, Ontario,
Canada). Serum supernatants were collected and stored at –80°C until analysis.
As mentioned, the feeding protocol occurred during the first 2h of the 4h recovery period
following the glycogen lowering exercise protocol. Specifically, participants were
provided with either KME or an isoenergetic appearance-matched placebo after the initial
blood sample. Thereafter, recovery drinks containing CHO were supplied every 15 min
for 2h of the 4h recovery period at a rate of 1.5 g·kg-1·h-1 (10-12% solution). Participants
remained in the lab for the following 2h (passive recovery) before engaging in both 20
and 5 km best effort time trials (TT20km and TT5km) (Figure 4.1).

Time Trials (TT20km and TT5km)
After the recovery period ended (4 h following the glycogen lowering exercise),
participants performed a 10-min warm-up cycling at 100 W on a Velotron cycle
ergometer and then completed a best effort TT20km. Then, after a 5 min recovery period
the best effort TT5km was completed. During both TT, participants received only distance
travelled feedback. This approach was implemented to minimize pacing strategies.
Average power output and time to complete total distance were recorded. Water was
available ad libitum throughout the time trial and the intake recorded (750.5±502.3 ml) so
it could be reproduced during the subsequent trial.

4.4 Statistical Analysis
Statistical analyses were performed using SigmaPlot for Windows (Version 12.5,
SYSTAT, San Jose, CA). Blood metabolites concentrations were analyzed using two-
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way (condition by time) repeated-measures ANOVA. Post hoc Tukey’s Honest
Significant Difference (HSD) testing was used, where necessary. All variables from the
TT20km and TT5km were analyzed using paired t tests. Significance was set at p ≤ 0.05.
Data are presented as means±SD.

4.5 Results
Blood Ketones (beta-hydroxybutyrate - βHB)
There was a main effect of time (p< 0.001), a main effect of treatment (p< 0.001), as well
as a significant interaction (p< 0.001) for blood beta-hydroxybutyrate (βHB)
concentration. Pairwise comparisons indicated that blood βHB was significantly greater
(p< 0.001) for KME + CHO group at 30 (p< 0.001), 60 (p< 0.001), 90 (p< 0.001), and
120 (p< 0.001) min post treatment ingestion, compared to PLAC + CHO group (Figure
4.2).

Figure 4.2. Capillary blood βHB concentration. Values are means ± SD. GLE = Glycogen
lowering exercise; KME + CHO = ketone monoester + carbohydrates; PLAC + CHO = isoenergetic placebo + carbohydrates. *Significantly different versus PLAC + CHO.
= treatment
ingestion (KME or PLAC).

= CHO drink. βHB = beta-hydroxybutyrate.
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Blood Glucose
A significant time x treatment interaction (p= 0.03) for blood glucose concentration was
seen (Figure 4.3). Pairwise comparisons showed that blood glucose was significantly
lower at 30-min (5.8 ± 0.6 vs 7.1 ± 0.8 mM, p= 0.003) and 60-min (6.1 ± 1.2 vs 7.2 ± 2.3
mM, p= 0.01) for KME + CHO compared to PLAC + CHO. In addition, there was a main
effect of time (p= 0.001) and a main effect of treatment (p= 0.05).

Figure 4.3. Blood Glucose concentration. Values are means ± SD. GLE = Glycogen lowering
exercise; KME + CHO = ketone monoester + carbohydrates; PLAC + CHO = iso-energetic
placebo + carbohydrates. *Significantly different versus PLAC + CHO.
= treatment ingestion
(KME or PLAC).

= CHO drink.

Measures of Exercise Performance
Time Trials (TT20km and TT5km)
There were no significant differences in time to complete the best effort TT20km
(38.4±2.25 min vs 38.9±1.56 min; p= 0.420) (Figure 4.4A) nor the best effort TT5km
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(9.5±0.65 min vs 9.5±0.88 min; p= 0.884) (Figure 4.4C). Likewise, there were no
significant differences in average TT20km power output (174±21.9 W vs 169±25.6 W; p=
0.427) (Figure 4.4B) nor average TT5km power output (182±31.8 W vs 186±40.5 W; p=
0.524) (Figure 4.4D). between KME + CHO vs PLAC + CHO trials. Average HR during
the TT20km and TT5km was 86% and 89% of age-estimated max HR, respectively.

Figure 4.4. Group means and individual data for A) time to complete and B) Average PO during
TT20km as well as C) time to complete and D) Average PO during TT5km. Values are means ±
SD. KME + CHO = ketone monoester + carbohydrates; PLAC + CHO = iso-energetic placebo +
carbohydrates.

4.6 Discussion
The aim of the present study was to assess the efficacy of acute glucose-ketone ester
supplementation on exercise performance after a 4-h recovery period following glycogen
lowering exercise, i.e., whether exercise recovery KME + CHO supplementation vs
PLAC + CHO might enhance time trial performance by improving glycogen resynthesis
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following glycogen lowering exercise. Our results indicate that KME + CHO displayed
greater βHB blood concentration throughout the recovery period and lower blood glucose
concentration during the first h of the recovery period, compared to the PLAC + CHO
trial. However, there were no significant differences in any of the exercise performance
parameters assessed during the TT20km and TT5km completed four h after glycogen
lowering exercise. These data suggest that glycogen resynthesis during our 4 h recovery
period was similar between treatments.
These data add to our understanding of KME supplementation on performance because
only a few studies have evaluated the role of exogenous ketone supplementation during
post-exercise recovery on muscle glycogen resynthesis in humans (Holdsworth et al.,
2017; Vandoorne et al., 2017) and those results are conflicting. For instance, Holdsworth
et al. (2017) found that muscle glycogen replenishment was superior (50% greater
content) when combining KME supplementation and glucose compared to glucose alone,
while Vandoorne et al. (2017) found no differences in muscle glycogen replenishment
after five h of recovery when using a CHO-PRO mix drink with and without KME
following glycogen depleting exercise. Although muscle glycogen content was not
measured in the present study, we did not observe any differences in exercise
performance after the recovery period (Figure 4.4), which suggests that both
experimental treatments resulted in similar rates of glycogen resynthesis. However, it is
possible that the TT20km and TT5km completed in this study were not long enough to
challenge glycogen stores, i.e., under both conditions, glycogen stores were sufficient,
even if differences existed. Consequently, a longer time trial and/or alternatively the use
effort independent measures such as muscle glycogen concentration might be needed to
reveal differences, if any.
Several mechanisms have been proposed to upregulate glycogen resynthesis after
exercise when using ketone supplementation. First, in both animal and human studies
βHB can activate proteins in the insulin-signaling cascade while downregulating AMPK
(Vandoorne et al., 2017; Takahashi et al., 2019). This results in non-AMPK-mediated
translocation of GLUT4 transporters and a downregulation of both glycogenolysis and
glycolysis, which could facilitate glucose uptake by the muscle cell as well as directing
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more muscle glucose toward glycogenesis (Takahashi et al., 2019). Second, elevated (>
4mM) blood βHB concentrations may lead to hyperinsulinemia especially if combined
with high glucose availability, and this could in turn, facilitate glycogen resynthesis. For
instance, Takahashi et al. (2019) demonstrated greater increases in glycogen content in
mice muscle after 120 min when the βHB concentration was set at 4mM, compared to
2mM and 1mM. In humans, Holdsworth et al. (2017) found increases in muscle glycogen
content after a single dose of 573 mg·kg-1 KME (peak blood βHB concentration of
5.3mM), compared to a glucose alone trial. In contrast, Vandoorne et al. (2017) found no
difference in muscle glycogen content when providing an initial dose of 500 mg·kg-1
KME and four subsequent doses of 250 mg·kg-1 KME at 1-h intervals (blood βHB
concentration of ~2.9mM after the first h of recovery and a peak concentration of 4.3mM
at four h of recovery). In our study, we provided participants with a single dose of ~350
mg·kg-1 KME and peak βHB concentration was only 2.7mM (Figure 4.2), something that
might have contributed to the lack of difference seen in our time trials. Alternatively, the
discrepancy in muscle glycogen content reported in these human studies could be
influenced by glucose availability because Biden and Taylor (1983) found that βHB does
not stimulate insulin release in the absence of glucose but can promote insulin secretion
in the presence of 5mM of glucose, at least in isolated rat pancreatic islets. These
observations suggest that insulin release from beta cells in response to βHB requires a
concurrent high-normal blood glucose. For example, using a hyperglycemic clamp in
humans to maintain glucose concentrations at ~10mM throughout the experiment,
Holdsworth et al. (2017) found a 50% increase in muscle glycogen content in a KME trial
after 2 h of recovery. This was associated with a twofold greater insulin concentration by
the end of the clamp and a 32% greater whole-body glucose uptake with KME. In
contrast, Vandoorne et al. (2017) did not observe differences in muscle glycogen content
nor blood insulin with KME supplementation even with blood glucose concentration at ~
6.5mM throughout a 5-h recovery period. In the present study, CHO was provided at 15min intervals to ensure a constant blood glucose response with KME (~6.1mM glucose
throughout the 2-h feeding period). Unfortunately, our blood insulin data are not yet
available due to COVID-19 restrictions but, given the exercise performance results
obtained, as well as βHB and glucose concentrations during the feeding period, we can
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speculate that insulin concentrations were similar between the two trials. These data
suggest that glucose bioavailability needs to be abundant for βHB to stimulate an
insulinotropic response. Moreover, glucose transport across the GI tract is a key factor in
absorption and the capacity of the glucose transporter (sodium-dependent glucose
transporter 1), requires ~1.3 to 1.7 g CHO·min-1 (Duchman et al., 1997). Importantly, it
has been shown that these transporters can be upregulated with a chronic high CHO diet,
i.e., ~8.5 g·kg-1·d-1 (Cox et al., 2010; Jeukendrup, 2017). In our study, participants
consumed only modest amounts (3.5 g·kg-1·d-1) of CHO (Table 4.1) and, of course, this
could have limited glycogen synthesis during the feeding/recovery period of this study.
Clearly, more research is warranted to elucidate the possible benefits of KME
supplementation in recovery and future investigations should ensure both high βHB
concentration and high glucose availability.
Interestingly, in our study the KME + CHO trial displayed lower glucose concentrations
during the first h of recovery. This observation is in agreement with the glucose response
seen by Vandoorne et al. (2017) where glucose was also lower at 60 and 90 min of
recovery. Moreover, this apparent hypoglycaemic action of βHB has also been reported
during exercise after KME ingestion (Cox et al., 2016; Evans and Egan, 2018; Dearlove
et al., 2019) as well as during βHB infusion studies in humans where the blood βHB
concentration was set ~2mM (Miles et al., 1981; Mikkelsen et al., 2015). Often these
differences in circulating glucose are explained partly by hyperinsulinemia, however, this
response can still occur even in the absence of high insulin, as observed in the Vandoorne
et al. (2017) study. Consequently, this hypoglycemic response might be explained by a
decrease in hepatic glucose production (gluconeogenesis) and hepatic output because
βHB infusion studies have shown a 20% decrease in endogenous glucose production in
healthy males (Miles et al., 1981; Mikkelsen et al., 2015). Of course, this response can
have important therapeutic implications. For instance, Soto-Mota et al. (2021) found
recently that 3 times a d KME supplementation for 4 wk was safe, well tolerated, and
resulted in improved glycaemic control in patients with type 2 diabetes.
In summary, KME + CHO supplementation resulted in a reduced blood glucose
concentration during the first h of recovery period, as well as greater βHB blood
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concentration throughout the recovery period, when compared to the PLAC + CHO trial.
However, no significant differences in any of the exercise performance parameters
measured during the TT20km and TT5km were observed. These data suggest that the
metabolic changes induced by the CHO and KME provided in this study is perhaps not
sufficient to elicit any potential benefits in subsequent exercise performance trials. In the
future, it is important to consider strategies to improve key factors such as feeding
protocols, CHO and βHB doses that ensure adequate glucose and ketone bioavailability,
as well as longer performance trials and/or effort independent assessment measures.
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Chapter 5
5

Exogenous ketone ester supplementation may improve some aspects of
cognitive function during a simulated soccer match after induced mental
fatigue
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5.1 Abstract
Exogenous ketone supplementation has been proposed as a way to enhance cognition
during exercise. However, whether these benefits are seen during intermittent exercise
after induced mental fatigue is unknown. We assessed whether a ketone monoester
supplement (KME) was superior to a non-caloric placebo (PLAC) in maintaining
cognitive performance during a 45-min simulated soccer match after induced mental
fatigue. Nine recreationally active men (174.3 ± 4.2 cm, 76.6 ± 7.4 kg, 30 ± 3 y, 14.2 ±
5.5 % body fat, V̇O2max= 55 ± 5 ml· kg BM−1·min−1; mean±SD) completed a 45-min
simulated soccer match consuming either KME (25g of βHB) or PLAC, after a 40-min
mental fatiguing task. The soccer match consisted of 3 blocks of various intensity
exercise. Cognitive function (Stroop test and Choice Reaction Task [CRT]) and blood
metabolites were measured during exercise. KME displayed lower concentrations of both
blood glucose (block 2: 4.6 vs 5.2 mM, p= 0.02; block 3: 4.7 vs 5.3 mM, p= 0.01) and
blood lactate (block 1: 4.7 vs 5.4 mM, p= 0.05; block 2: 4.9 vs 5.9 mM, p= 0.01) during
exercise, compared to PLAC, perhaps indicating a CHO sparing effect. Although both
treatments resulted in a decrease in %correct answers for the CRT during exercise
relative to baseline, KME displayed a smaller decrease compared to PLAC (1.3 vs 3.4 %,
p= 0.02). No other differences in cognitive function were seen. These data suggest that
KME supplementation can improve some aspects of cognitive function during high
intensity intermittent exercise. However, more study is warranted to assess fully the
potential cognitive/physical benefits of KME for athletes.

Keywords: exogenous ketones, ketosis, soccer, intermittent exercise.
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5.2 Introduction
In team sports of moderate to long duration such as soccer, a high cognitive and physical
demand is imposed as athletes are required to make numerous split-second decisions that
can influence the outcome of the competition while performing high intensity actions
such as sprinting, jumping, tackling, etc (Smith et al., 2018). Often, the onset of fatigue
occurs towards the end of a match and is associated with depletion of glycogen stores
(Krustup et al., 2006; Cermak and Van Loon, 2013). During this time, athletes may
experience physical fatigue evidenced by a decrement in work output (Bangsbo et al.,
1991; Rampinini et al., 2007), as well as increased mental fatigue exhibited as poor
decision making or deterioration of skills (Baker et al., 2014; Smith et al 2016; Quinones
and Lemon, 2019). This is important as the abovementioned factors are critical
determinants of game play. In light of this, nutrient supplementation strategies to avoid or
delay the onset of fatigue are of considerable interest to many.
Ketone bodies (KB) are lipid derived metabolites produced in the liver during periods of
low CHO availability such as starvation, prolonged exercise, uncontrolled diabetes, or
dietary manipulations (Laffel, 1999; Puchalska and Crawford, 2017). Aside from glucose,
KB are the only energy substrate that can cross the blood brain barrier through
monocarboxylate-mediated transport (Evans et al., 2017). This allows them to act as an
alternative fuel for the brain while reducing glucose reliance, something that might help
enhance cognitive performance (Evans et al., 2017; Valenzuela et al., 2021). In addition,
KB can increase the expression of the protein Brain Derived Neurotropic Factor (BDNF),
an important molecule for brain plasticity/regulation of cognitive function (Marosi et al.,
2016; Sleiman et al., 2016). Recently, exogenous ketone supplements have emerged as an
alternative to a ketogenic diet in order to induce hyperketonemia acutely (Cox et al.,
2016; Stubbs et al., 2017) and are available commercially in two forms, ketone salts (KS)
and ketone esters (KE). These supplements have been shown to help spare CHO (Cox et
al., 2016) and to provide an alternative fuel for the brain (Cunnane et al., 2011).
However, only a few studies have evaluated the efficacy of exogenous ketone
supplements on cognitive function during exercise with some studies showing positive
effects (Evans and Egan, 2018; Prins et al., 2020) while others found no change
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(Waldman et al., 2018; Evans et al., 2019; Waldman et al., 2020) when compared to
CHO or a non-caloric placebo. This discrepancy has been attributed, in part, to the use of
KE (Evans and Egan, 2018; Evans et al., 2019) vs KS (Waldman et al., 2018; Prins et al.,
2020; Waldman et al., 2020), as the former can induce greater circulating KB (Stubbs et
al, 2017), as well as other procedural differences (Margolis and O’fallon, 2020). For
example, most studies have measured cognition before and after exercise as opposed to
during exercise. The latter would have greater ecological validity as cognitive changes
are likely rapid in recovery from exercise. Further, it has been shown that cognitive
function displays greater impairments when the tests and physical exercise are performed
concurrently (Lambourne and Tomporowski, 2010), possibly due to a dual-task
interference. To our knowledge, only one ketone supplementation study has measured
cognitive function during steady state exercise, it used KS, a supplement that only
induces slight to modest increases in circulating KB (Waldman et al., 2020), and it found
no changes in cognition when compared to a non-caloric placebo. Whether the effects of
exogenous KE are similar during high intensity, intermittent exercise, like that performed
in a soccer match, is unknown. Therefore, the purpose of the present study was to assess
whether ketone monoester (KME) supplementation can enhance/maintain cognitive
performance during a 45-min simulated soccer match after induced mental fatigue. We
hypothesized that KME supplementation would enhance/maintain cognitive function
during the simulated soccer match.

5.3 Methods
Participants
A total of 14 healthy, male soccer players were recruited but five participants did not
complete the entire experimental protocol due to laboratory closures and restrictions
during the COVID-19 pandemic. These five participants were excluded from data
analysis and the remaining nine were included in the study (height = 174.3 ± 4.2 cm,
body mass = 76.6 ± 7.4 kg, age = 30 ± 3 y, body fat = 14.2 ± 5.5%, and V̇O2 max = 55 ±
5 ml· kg BM−1·min−1). All were experienced, recreational soccer players from a range of
outfield playing positions who had been involved in soccer training/play at least 2 d per

70

week for 6 mo prior to the study. Each participant completed a physical activity readiness
questionnaire (PAR-Q+ - Thomas et al., 1992) and a health information form to minimize
any contraindications to exercise. All potential risks were explained fully prior to any
testing, and the participants provided written, informed consent of the study protocol
approved previously by the Western University’s Office of Research Ethics.

General Study Design
A double blind, randomized, crossover research design was implemented involving two
preliminary and two experimental sessions that comprised two treatments, KME (TdeltaS
Ltd, Thame Oxfordshire, United Kingdom) or a non-caloric appearance-matched placebo
(PLAC) (Crystal Light, Kraft Ontario, Canada). The preliminary sessions were conducted
before any experimental sessions began and were used to collect baseline data needed to
design the running protocol to be implemented in the experimental sessions, as well as to
acclimate participants to all the cognitive function tests and measurements utilized during
the experimental sessions. These preliminary sessions were separated by at least two d
and the second session was completed at least five d before starting the experiment. The
two experimental sessions were separated by at least one wk, were conducted at the same
time of the day, and were rotated systematically to prevent order effects. Further, to
minimize food intake differences across treatments, participants recorded their entire
food/drink intake for the d preceding and the d of the first experimental session and
replicated this intake for their second trial. Experimental sessions were comprised of a
40-min mental fatiguing task (MFT), followed by a 45-min simulated soccer match
(Figure 5.1). Participants performed both sessions while receiving either 25g (329 ± 34
mg·kg−1) of ketones (KME) or placebo (PLAC). Both drinks were 125ml in volume and
were provided in plastic cups. Cognitive function (Stroop test and Choice Reaction Test
(CRT) – see details below), blood metabolites, rates of perceived exertion, mental fatigue
and mental effort were measured before, during and after exercise (Figure 5.1).

71

Figure 5.1. Overview of study protocol. MFT = mental fatiguing task. CRT = choice reaction
test.

Preliminary Sessions
As mentioned, participants visited the laboratory on two separate occasions prior to any
experiments for familiarization sessions. During the initial visit, body composition (Bod
Pod®, COSMED, Concord, CA) V̇O2max (running treadmill test), and maximal sprinting
speed (treadmill test) were determined. Briefly, body density was measured using the
BodPod® and body composition was estimated from the measured body density with the
Siri (Siri, 1961) equation. V̇O2max was determined via an incremental speed protocol on
a treadmill (Desmo Pro, Woodway®, Wisconsin, USA). Participants started running at
9.7 km•h-1 h with the treadmill set at a constant grade of 1%. Subsequently, increases in
speed of 0.16 km •h-1 every 12 sec were applied until volitional fatigue. Heart rate (HR)
was monitored throughout the test (Polar RST200TM, Polar Electro Inc., Lachine,
Quebec) and expired gases were analyzed via a breath-by-breath collection system
(Sensormedics Vmax 29, Yorba Linda, CA), calibrated according to manufacturer’s
guidelines using known gases volumes and composition. The greatest value achieved
over a 20-s collection period was considered max whenever a plateau in V̇O2 occurred
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(<50% of the expected increase in oxygen uptake for the increased workload) or when
two of the following three criterion measures were attained (±10 bpm of age predicted
maximum HR, RER >1.15 [RER = volume of CO2 produced/volume of O2 consumed] or
volitional fatigue). Furthermore, peak sprint speed was determined using a 10-s all-out
effort on a non-motorized treadmill (Desmo Pro, Woodway®, Wisconsin, USA). Briefly,
at a 2% incline with a disengaged belt, each participant propelled the belt themselves and
the greatest speed shown on the treadmill display board during the test was recorded as
peak speed.
At least 48 h following the first visit, participants returned the lab a second time to
familiarize themselves with both the cognitive tests and the high intensity intermittent
running protocol used to simulate the second half of the soccer match. This was done to
eliminate potential learning effects during the experimental sessions.

Experimental Sessions
Participants reported to the laboratory 4 h postprandial with limited activity (drive/use of
the elevator to get to the laboratory), having abstained from strenuous exercise, caffeine,
or alcohol consumption for 24 h. This dietary control was utilized not only to standardize
conditions between treatments but also to ensure that participants were able to exercise in
a fed state, as this is how people engage in competition typically. Upon arrival, capillary
blood samples for baseline glucose, beta-hydroxybutyrate (βHB) (FreeStyle Precision
Neo®, Abbott Diabetes Care Limited) and lactate (Lactate Scout+, EKF Diagnostics)
concentration were obtained using the fingerstick method. Subsequently, baseline ratings
of mental fatigue were collected using a 100-mm visual analog scale (VAS) and then, the
mental fatiguing task (MFT) commenced. For the MFT, a longer version of the Stroop
task (40 min) was implemented as this approach has been shown to induce a state of
mental fatigue previously (Smith et al., 2016). Following the MFT, pre-exercise cognitive
function was assessed using both the Stroop test and CRT. Ratings of mental fatigue and
mental effort were collected using a 100-mm VAS. Next, capillary blood samples to
assess blood metabolites were collected and the corresponding treatment (KME or
PLAC) was given. Five min after drink ingestion, a 5-min warm-up was completed,
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followed by a 45-min simulated soccer match (Figure 5.1). The simulated soccer match
was comprised of 3 x 15-min intermittent running blocks interspersed with 3-min of
passive recovery. The intensities and times used during each block were full stopping (15
s), walking (35 s), jogging (46 s at 55% V̇O2max), cruising (42 s at 95% V̇O2max) and
sprinting (17 s at 90% of peak sprint speed). This protocol has been used in our
laboratory previously (Quinones and Lemon, 2019) and has been shown to replicate the
physiological demands of soccer play (Drust et al., 2000). Heart rate was monitored
throughout using a Polar RST200TM (Polar Electro Inc., Lachine, Quebec). Capillary
blood samples to measure glucose, βHB and lactate, as well as ratings of perceived
exertion (RPE – 6-20 Borg scale) were taken before commencing the simulated match
and during each 3-min passive recovery throughout.

Cognitive Function Tests
Two cognitive function tests were used, the Stroop test and Choice Reaction test (CRT).
The Stroop test was used for the MFT (40-min) to induce mental fatigue, and together
with the CRT during the exercise bout to assess cognition. A computer screen was set up
in front of the treadmill and a box with four buttons to respond to the stimuli presented on
the screen was placed in front of the participant.

The Stroop Test
The Stroop test evaluates selective attention and ability to inhibit a learned skill
consciously (Stroop, 1935; MacLeod, 1991). For this test, words of four colours (red,
blue, yellow, and green) were displayed in the centre of the computer screen written in
either congruent (i.e., word ‘blue’ written in blue ink) or incongruent ink (i.e., word
‘blue’ written in green ink). Each test was comprised of 44 random trials (4 practice trials
where on-screen feedback [correct / incorrect] was given + 20 congruent and 20
incongruent trials with no feedback). Using the 4-button box, participants responded by
pushing the button that matched the color displayed on the computer screen, not the
word. This test was performed twice within each exercise block for a total of 264 trials
(24 practice trials, 120 congruent and 120 incongruent) during the soccer match
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simulation. The Stroop effect was quantified as the difference in mean choice-reaction
time between congruent and incongruent trials. The task was scored as the difference in
mean choice reaction time (ms), accuracy (%) and Stroop effect (ms) from baseline (preexercise) relative to exercise.

Choice Reaction Test (CRT)
For this test, the computer screen was divided into four equal-area quadrants and each
area was assigned a specific response key in the 4-button box located in front of the
participants. Stimuli sporadically flashed on the screen and participants were instructed to
respond as quickly as possible by pushing the button on the box that corresponded to the
location of the stimuli on the screen. This test was performed twice within each exercise
block, with each test comprised of 80 random trials, for a total of 480 trials during the
soccer match simulation. The task was scored as the difference in mean choice reaction
time (ms) and accuracy (%) from baseline (pre-exercise) relative to exercise.

5.4 Statistical Analysis
Statistical analyses were performed using SigmaPlot for Windows (Version 12.5,
SYSTAT, San Jose, CA). Blood metabolites concentrations as well as ratings of
perceived exertion, mental fatigue and mental effort were analyzed using two-way
(condition by time) repeated-measures ANOVA. Post hoc Tukey’s Honest Significant
Difference (HSD) testing was used, where necessary. The Stroop test and CRT were
analyzed using a paired t test. Significance was set at p ≤ 0.05. Data are presented as
means±SD.

5.5 Results
Blood Metabolites
There was a significant treatment × time interaction (p< 0.001) for blood βHB (Figure
5.2A). Pairwise comparisons showed that blood βHB concentration was greater for KME
after warm-up (0.97 ± 0.48 vs 0.1 ± 0.09 mM, p< 0.001) and during all 3 exercise blocks

75

- block 1 (1.48 ± 0.32 vs 0.09 ± 0.06 mM, p< 0.001), block 2 (1.63 ± 0.50 vs 0.12 ± 0.08
mM, p< 0.001) and block 3 (1.61 ± 0.60 vs. 0.16 ± 0.08 mM, p< 0.001), compared with
PLAC. In addition, there were main effects of both time (p< 0.001) and treatment (p<
0.001) for blood βHB concentration. As expected, blood βHB was greater at every time
point after supplement ingestion, compared to both baseline and post-MFT.
There was a significant treatment × time interaction (p= 0.02) for blood glucose (Figure
5.2B). Pairwise comparisons showed that blood glucose was greater for PLAC in block 2
(5.2 ± 0.6 vs 4.6 ± 0.6 mM, p= 0.02) and block 3 (5.3 ± 0.8 vs 4.7 ± 0.9 mM, p= 0.01),
compared with KME. In addition, no main effect of treatment was found (p= 0.58) but
there was a main effect of time (p= 0.02) for blood glucose concentration showing that
blood glucose was lower post-MFT, compared to baseline.
A main effect of time (p < 0.001) was also detected for blood lactate (Figure 5.2C). As
expected, lactate concentrations were greater during exercise relative to baseline and
post-MFT. No treatment effect (p= 0.47) was observed but there was a treatment x time
interaction (p= 0.02). Pairwise post hoc comparisons indicated that blood lactate
concentration was greater for PLAC for exercise block 1 (5.4 ± 1.8 vs 4.7 ± 1.4 mM, p=
0.05), and block 2 (5.9 ± 2.5 vs 4.9 ± 1.9 mM, p= 0.01), compared with KME.
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Figure 5.2. Effects of KME ingestion on blood metabolites during exercise after induced mental
fatigue. A) blood βHB concentration B) blood glucose concentration C) blood lactate
concentration. Values are means ± SD. MFT = mental fatiguing task; WU = warm-up; KME =
ketone monoester supplement; PLAC = non-caloric placebo. *Significantly different versus
PLAC.

Visual Analog Scales
Subjective ratings of mental fatigue increased significantly in both trials after the mental
fatiguing task (p= 0.003) and after exercise (p< 0.001), compared to baseline. However,
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no differences were found between KME and PLAC at any time point (p= 0.53) (Figure
5.3A).
Subjective ratings of mental effort were calculated as the difference between pre- and
post-exercise ratings. A paired t test showed no difference in mental effort under both
KME and PLAC conditions (p= 0.47) (Figure 5.3B).

Figure 5.3. Effects of KME supplementation on subjective ratings of mental fatigue and mental
effort A) Subjective ratings of mental fatigue B) difference in subjective ratings of mental effort,
relative to pre-exercise (Post MFT). Values are means ± SD. MFT = mental fatiguing task; KME
= ketone monoester supplement; PLAC = non-caloric placebo. VAS = Visual Analogue Scale

Ratings of Perceived Exertion (RPE)
A main effect of time (p< 0.001) was detected for RPE (Table 1). As expected, average
RPE for block 2 and block 3 were greater than both pre-exercise and block 1. No
treatment effect (p= 0.90) nor treatment x time interactions were observed (p= 0.13).
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Table 5.1. Ratings of perceived exertion (RPE)
KME

PLAC

Two-way RM ANOVA

Pre-SSM

9.3 ± 1.0

9.9 ± 1.1

Time Effect

p < 0.001

Block 1

13.2 ± 1.0 a

12.8 ± 1.1 a

Treatment Effect

p = 0.90

Block 2

14.7 ± 1.4b

14.8 ± 1.4b

Block 3

15.9 ± 1.8b

15.8 ± 1.6b

Interaction Effect

p = 0.13

Values are means ± SD. RPE data was analyzed using two-way repeated measures ANOVA. Post hoc
Tukey’s HSD testing was used to figure out differences between treatments. There were no significant
differences between KME and PLAC (p= 0.13).
SSM = Simulated Soccer Match
a
indicates significant difference from Pre-SSM
b
indicates significant difference from Pre-SSM and Block 1

Cognitive Function
The Stroop test was used to assess cognition before and during exercise. The difference
between all variables pre-exercise vs during exercise were calculated and compared using
paired t testing. Results showed that there were no differences in reaction tine for
congruent (p= 0.78) or incongruent (p= 0.43) trials, as well as no differences in the
percent of correct answers for congruent (p= 0.38) and incongruent (p= 0.16) trials.
Lastly, there were no differences in Stroop effect (p= 0.44) when comparing KME to
PLAC group (Table 5.2).
Moreover, a choice reaction test (CRT) was used as well to measure cognition before and
during exercise. Similarly, the difference between all variables pre- exercise vs during
exercise were calculated and compared using paired t tests. Results revealed that
compared to PLAC, the KME group displayed a reduced decrease in the percent of
correct answers during exercise (p= 0.02), while maintaining a similar increase in
reaction time (p= 0.11), indicating a better maintenance of cognitive function with KME
(Figure 5.4).
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Table 5.2. Stroop test
Variable measured

Treatment

∆Score

P-value

RT (ms)

KME
PLAC

26.7 ± 60.4
22.4 ± 50.2

0.78

Percent Correct (%)

KME
PLAC

3.6 ± 4.7
1.9 ± 2.2

0.38

RT (ms)

KME
PLAC

24.9 ± 111.4
0.31 ± 62.0

0.43

Percent Correct (%)

KME
PLAC

4.4 ± 5.4
5.4 ± 5.6

0.16

Congruent

Incongruent

-1.8 ± 68.3
0.44
-22.1 ± 71.6
Values are means ± SD. The difference in pre-exercise Stroop task (post MFT) and during exercise were
calculated for all variables (∆Score). Data was analyzed using a paired t test. There were no significant
differences between KME and PLAC.

Stroop effect

KME
PLAC

5.6 Discussion
The purpose of the present study was to assess the efficacy of acute KME
supplementation on cognitive performance during a 45-min simulated soccer match after
induced mental fatigue. Interestingly, our results revealed that relative to pre-exercise, the
number of correct answers was better maintained with KME during exercise compared to
PLAC, while reaction time remained similar in the CRT. In contrast, no differences were
seen with the Stroop test when comparing both treatments. As expected, KME
supplementation elevated blood βHB, lowered blood glucose the last 30 min of exercise,
and lowered blood lactate during the first 30 min of exercise perhaps indicating a shift in
exercise fuel use away from CHO.
Previous investigations evaluating the effects of ketone supplements on cognitive
function using exercise have produced mixed results, with a few studies showing positive
outcomes (Evans and Egan, 2018; Prins et al., 2020), and others showing no benefits
(Waldman et al., 2018; Evans et al., 2019; Waldman et al., 2020). Part of the discrepancy
has been attributed to factors such as the type of supplement used (KS vs KE) or differing
methodology (Margolis and O’fallon, 2020). For example, KE have been shown to
induce a greater ketonemia compared to KS (Stubbs et al., 2017). This is likely important
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Figure 5.4. Effects of KME supplementation on cognitive function (CRT) during exercise after
induced mental fatigue, compared to PLAC. A) ∆ reaction time during exercise, relative to preexercise (Post MFT) B) ∆% correct answers during exercise, relative to pre-exercise (Post MFT).
Values are means ± SD. MFT = mental fatiguing task; KME = ketone monoester supplement;
PLAC = non-caloric placebo.

because the magnitude of ketosis (in the range of ∼1 to 3 mM) has been deemed essential
to induce certain physiological changes (Evans et al., 2017). In the present study,
participants ingested KME and reached a blood βHB concentration of ~1.6mM. A
previous study that also found cognitive function improvements provided KME at a
greater dose (750 mg·kg−1) and generated blood βHB concentrations of ~2.6mM (Evans
and Egan, 2018). In contrast, Walmand et al. (2018; 2020) provided KS and reported no
benefit on cognitive function. In these studies, participants achieved a blood βHB
concentration of ~0.5 mM (Walmand et al., 2018) and ~0.8 mM (Walmand et al., 2020).
Furthermore, the difference in the mode of exercise (intermittent vs continuous) as well
as the time when the cognitive tasks are administered may also affect the outcomes. For
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instance, Evans and Egan (2018) demonstrated that supplementing with KME and CHO
before and during a ~90-min intermittent exercise session reduced the number of
incorrect responses during a cognitive test administered after exercise, when compared to
CHO alone. However, the same authors found no benefits when these cognitive tasks
were performed after a 10 km time trial (Evans et al., 2019). Perhaps exercise mode and
duration contributed to these differing results. In the present study, participants
performed only 45-min of intermittent exercise, although it was done in a state of preinduced mental fatigue. Our findings are consistent with Evan and Egan (2018), since
participants ingesting KME in our study were able to reduce the number of incorrect
answers relative to baseline during the CRT, compared to PLAC. This is likely important
for team sports because CRT has been shown to provide insight on individual decisionmaking under pressure (Ozdemir et al., 2010). Further, Evans and Egan (2018)
administered their cognitive task before and after exercise, while in the present study it
was done concurrently with exercise, something that enhances ecological validity and this
timing difference may be important. For example, Lambourne and Tomporowski (2010)
observed small improvements in cognitive function when tests were completed after
exercise cessation whereas a slight impairment was seen when tests were done during
exercise, something that would make any cognitive task more sensitive to detect a
potential difference. However, this apparent benefit of KME supplementation was not
detected with the Stroop test in the present study. A possible explanation for this could be
that participants had accrued some learning during the mental fatiguing task, perhaps
making the treatment test less sensitive to detect any differences. As mentioned, the
Stroop test was used during the initial 40-min of the study protocol to induce a state of
mental fatigue. Consistent with Smith et al. (2016) this approach was effective at
increasing subjective ratings of mental fatigue (Figure 5.3A) but given the duration of the
task, it could be that our participants were accustomed to the stimuli presented, making it
less likely to find an effect during exercise, if any. Nonetheless, these results should be
interpreted with caution and more study is needed to confirm the present findings.
Interestingly, metabolic responses appeared to differ in our study between the two
treatments. As expected, KME ingestion elevated blood βHB during exercise vs PLAC,
an effect that has been consistent across studies using ketone supplementation (Margolis
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and O’fallon, 2020; Valenzuela et al., 2020; Valenzuela et al., 2021). Furthermore, KME
lowered blood glucose in the last 2 blocks of exercise (block 2: 4.6 vs 5.2 mM, p= 0.02;
block 3: 4.7 vs 5.3 mM, p= 0.01), and reduced blood lactate during the first 2 blocks of
exercise (block 1: 4.7 vs 5.4 mM, p= 0.05; block 2: 4.9 vs 5.9 mM, p= 0.01). These
metabolic responses are consistent with the majority of studies using KME
supplementation during exercise (Cox et al., 2016; Evans and Egan, 2018; Dearlove et
al., 2019), particularly for the one that measured cognitive function and found small
improvements as well (Evans and Egan, 2018). Interestingly, one KME study examining
cognitive function did not observe such metabolic responses nor any differences in
cognition (Evans et al., 2019). Originally, it was argued that these metabolic responses
are indicative of a potential CHO sparing effect, because the first study reporting these
metabolic changes found improvements in physical performance following KME
ingestion (Cox et al., 2016). However, subsequent investigations have suggested that high
blood βHB concentrations also lowers pH and these perturbations to acid-base
homeostasis could reduce the rate of glycolysis and thus lactate production (Dearlove et
al., 2019). Of course, this could affect soccer performance adversely. However, it is
important to note that these perturbations have been reported only when blood βHB
concentrations is raised substantially. For example, Dearlove et al. (2019) found that
power output did not differ at high exercise intensities despite a blood βHB concentration
of ~ 3.7 mM. In our study, average blood βHB concentration was ~ 1.6 mM during
exercise, so it is plausible that acidosis-induced detriments would be minimal. If so, the
present data may be caused by a CHO sparing effect. Unfortunately, physical
performance was not assessed directly in the present study so whether the aforementioned
differences might enhance exercise performance must await further experimentation.
In conclusion, KME supplementation vs a non-caloric placebo resulted in fewer cognitive
errors relative to baseline in the CRT, while no differences were observed in any other
cognitive variable measured during intermittent exercise. Furthermore, KME
supplementation elevated circulating βHB and produced lower concentrations of both
glucose and lactate during exercise. These data suggest that KME supplementation has
the potential to improve some aspects of cognitive function during sports characterized
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by repeated, intense, intermittent exercise. However, more study is needed to assess fully
the possible cognitive/physical benefits of KME for athletes.
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6
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6.1 General discussion
Exogenous ketone (EK) supplementation has emerged recently as a potential aid for
exercise performance. Oral administration of EK in healthy adults leads to an acute state
of ketosis or hyperketonemia that can last up to 3 h (Stubbs et al., 2017). Ketosis is
defined as a plasma ketone concentration of ~0.5–3.0 mM (Gibson and Sainsbury, 2017).
This transient elevation of ketone bodies (KB) promote important metabolic changes
proposed to aid both exercise performance and post-exercise recovery (Valenzuela et al.,
2021). For instance, EK have not only been shown to reduce muscle glycogen utilization
while increasing fat oxidation during exercise (Cox et al., 2016) but also to improve some
aspects of cognitive function during exercise (Evans and Egan, 2018; Prins et al., 2020).
The latter could be important for success in many competitive sports because split-second
decisions are required throughout games. Moreover, EK in combination with CHO have
been shown to be better than CHO alone for post-exercise glycogen repletion
(Holdsworth et al., 2017). However, not all EK studies have observed these potential
ergogenic effects (Rodger et al., 2017; Leckey et al., 2017; O’Malley et al., 2017;
Waldman et al., 2018; Evans et al., 2019; James and Greer, 2019; Poffe et al., 2020;
Poffe et al., 2021). Consequently, it is difficult to determine the efficacy of these
supplements on competitive sports performance. As mentioned previously, several
factors such as type of EK supplement (esters vs salts), dose of supplement, exercise
modality, as well as the exercise tests used, appear to contribute to the discrepancies seen
in the literature to date.
In this dissertation, the goal was to explore the role of EK supplementation and help
elucidate the potential ergogenicity of EK. In study 1, the results are consistent with the
literature indicating that ketone salts (KS) are likely not ergogenic (Margolis and
O’fallon, 2020; Valenzuela et al., 2020; Valenzuela et al., 2021) possibly because they
induce only modest increases in blood ketones. Further, the experiments that have shown
KS supplements to improve exercise performance (Kackley et al, 2020) are likely due to
several other added ingredients such as caffeine and taurine. Specifically, in the first
study, the comparison amongst a caffeine-containing KS supplement vs the same
supplement without caffeine and an iso-energetic placebo was made. Results showed that

89

the caffeine-containing group improved performance on a best effort TT20km when
compared to the other two supplements, and that both KS supplements improved Wingate
peak power output. Both caffeine (Grgic et al., 2020) and taurine (Warnock et al., 2017)
have been shown to be ergogenic so it is likely that both contributed to these performance
benefits. The presence of these other components makes the role of KS on exercise
performance difficult to determine based on the data gathered in this dissertation. .
Importantly, it has been suggested that a minimum blood βHB concentration of >1mM is
important to elicit positive effects of ketone supplementation during exercise (Margolis
and O’fallon, 2020) and neither of the two KS supplements used in study 1 attained this
concentration (peaked at 0.7 mM). This may have been because of the supplement type,
i.e., KS and/or because of ingesting them in the fed state, which has been shown to slow
supplement’s absorption (Stubbs et al., 2017).
This dissertation also explored the potential for ketone monoesters (KME) to improve
important aspects of performance such as post-exercise recovery and cognitive function
during exercise. KME can induce a greater degree of ketonemia, and, because of this,
have been considered more effective than KS. Specifically, KME, the type of supplement
used in studies 2 and 3 of this dissertation, contain a βHB molecule bound through an
ester bond to 1,3 Butanediol, a ketogenic precursor that can be absorbed and converted to
βHB in the liver to induce a greater degree of ketonemia. In animals, infusion (Laughlin
et al., 1994) and incubation (Maizels et al., 1977; Takahashi et al., 2019) studies have
demonstrated that ketones (both acetoacetate and βHB) and CHO together results in
greater glycogen resynthesis vs CHO alone. A recent animal study showed that when
mice muscles were incubated with optimal glucose and insulin availability in a βHB
environment (1 vs 2 vs 4 mM), the greatest concentration displayed more glycogen
repletion after exercise (Takahashi et al., 2019). In humans, only two studies have
explored this issue with conflicting results. During recovery from glycogen depleting
exercise, Holdsworth et al. (2017) found a 50% increase in muscle glycogen content with
oral KME and intravenous CHO supplementation (glucose clamp maintaining
concentration at ~10mM) , compared to a glucose clamp alone, whereas Vandoorne et al.
(2017) observed no difference in glycogen content with oral KME and PRO + CHO
(glucose concentration achieved was ~ 6.5 mM) or PRO + CHO alone. Of course, greater
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initial glycogen content is associated with better performance not only in high intensity
intermittent sports (Saltin, 1973; Krustup et al., 2006) but also in prolonged endurance
efforts (Coyle et al, 1986). In study 2 of this dissertation, exercise performance was
compared with KME and CHO supplementation vs isoenergetic CHO alone, following
glycogen lowering exercise and the data indicate that KME and CHO supplementation
did not improve time trial performance. Based on these results and the methodology of
the previous two investigations (Holdsworth et al., 2017; Vandoorne et al., 2017), it
appears likely that a βHB concentration of >4mM and a high glucose availability
(~10mM) is necessary to enhance exercise recovery glycogen storage. In the future, doses
should be optimized to ensure sufficient glucose and ketone bioavailability.
In addition, the dissertation plan included an exploration of the potential of KME
supplementation to enhance or attenuate decrements in cognitive function observed often
during prolonged exercise (Study 3). The underlying rationale is that KB have been
shown to serve as an alternative fuel for the brain (Cunnane et al., 2011) as well as
serving as important signalling molecules increasing the expression of the protein Brain
Derived Neurotropic Factor (BDNF), known to influence brain plasticity and the
regulation of cognitive function (Marosi et al., 2016; Sleiman et al., 2016). In fact,
several previous studies had shown positive effects of KME (Evans and Egan, 2018) and
KS + MCT (Prins et al., 2020) supplementation on cognitive function. In study 3, this
dissertation evaluated whether KME supplementation could help attenuate cognitive
decline during intermittent exercise after induced mental fatigue, compared to a noncaloric placebo. As expected, the results indicated that mental fatigue decreased the
number of correct answers in both supplement groups with exercise, relative to baseline.
However, KME vs a non-caloric placebo attenuated the cognitive decline, although no
other cognitive benefits were observed during the intermittent exercise studied.

6.2 Limitations
This dissertation aimed to explore the role of ketones on various aspects of exercise
performance. While some of the results obtained in the three investigations help elucidate
the role of EK supplementation, several limitations need to be noted. For example, in
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study 1, both supplements studied contained other ingredients such as leucine and taurine,
and differed only with respect to the presence of absence of caffeine. This, of course,
makes it difficult to reach a definitive conclusion regarding KS. Future studies need to
isolate these other ingredients. In study 2 and 3, a more effective type of EK (KME) was
used. The dose administered was based on manufacturer’s guidelines and while some
positive effects were seen in cognitive function during exercise (βHB concentration
>1mM) the resulting ketonemia may have been suboptimal, i.e., <4mM βHB
concentration, for post-exercise glycogen resynthesis. Furthermore, studies 2 and 3 were
ongoing during the COVID-19 pandemic and, due to laboratory closures, the number of
participants was less than originally planned. While some important effects were
revealed, this reduced number of participants may have produced a statistical type II
error, relative to the potential benefits of EK supplementation. Finally, a glycogen
lowering exercise treatment based on previous literature was implemented in study 2 in
order to assess any performance benefits but glycogen measures were not taken.
Consequently, the degree of glycogen depletion could have differed amongst participants
and, if so, this could have affected the glycogen repletion.

6.3 Summary and Conclusion
In summary, study 1 demonstrated that ingestion of both a caffeinated KS supplement
and the same KS supplement without caffeine induced only a modest elevation in blood
βHB concentration (~0.7 mM). Both supplements improved Wingate peak power output,
following a 20 km time trial (TT20km); however, only the caffeinated KS supplement
improved performance on a best effort TT20km. Further, study 2 found that, despite
reduced blood glucose and greater βHB concentration, co-ingestion of KME and CHO
after glycogen lowering exercise (GLE) vs isoenergetic CHO alone, resulted in no
significant differences in any of the exercise performance parameters. These exercise
performance data are consistent with similar glycogen replenishment in both trials.
Finally, study 3 observed that, following induced mental fatigue, KME supplementation
resulted in fewer cognitive errors during exercise in a complex reaction test, compared to
a non-caloric placebo.
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In conclusion, the data from this dissertation indicate that 1) acute KS supplementation is
not likely to be ergogenic nor detrimental for exercise performance, 2) KME
supplementation may improve some aspects of cognitive function during exercise, and 3)
KME supplementation has little effect on post-exercise glycogen synthesis following
prior exercise. Finally, there are limited studies investigating these issues in the literature,
and, therefore, more study is needed to assess fully the possible benefits of KE for
athletes.

6.4 Future studies
As indicated, the degree of ketonemia appears to be a key factor promoting any
physiological/biochemical benefit. Therefore, dosage studied is critical. For example, it
appears that ketonemia needs to be ~ 4mM to induce important effects during postexercise recovery such as hyperinsulinemia. Further and importantly, this same degree of
ketonemia may affect exercise performance negatively due to perturbations to acid-base
homeostasis. One of the main challenges in the ketone supplementation area of study is
the conflicting results observed to date perhaps due to high heterogenicity of
experimental methodology. Important considerations include: 1) ketone supplement type
and dose as both determine the magnitude of ketosis achieved and 2) whether acute
ingestion occurs in the fed vs fasted state because the former slows absorption
significantly (Stubbs et al., 2017). Moreover, several other factors to consider are the
tests studied and the mode of exercise used to evaluate performance as these have
differed across studies published to date. Finally, it is recommended that future ketone
supplementation studies 1) use KME, 2) document the degree of induced ketosis so that
any possible effect threshold can be established, and 3) for post exercise glycogen
resynthesis studies, CHO availability be quantified.
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Appendix D. Letter of Information and Informed Consent study 1

Title of Study:

The effects of pure therapeutic ketones/caffeine free
supplementation vs caffeinated pure therapeutic ketones on a 20
Km time trial and a Wingate test exercise performance.

Principal Investigator: Dr. Peter W.R. Lemon (PhD) plemon@uwo.ca
Graduate Student: Manuel Quinones (MSc.) mquinon2@uwo.ca
Exercise Nutrition Research Laboratory (Room 2235 – 3M Centre)
School of Kinesiology, Western University.
LETTER OF INFORMATION AND CONSENT
INVITATION TO PARTICIPATE
You are being invited to participate in a research study at the Exercise Nutrition
Research Laboratory (Room 2235, 3M Centre) investigating the effects of pure
therapeutic ketones/caffeine free supplementation vs caffeinated pure therapeutic
ketones on a 20 Km time trial and a Wingate test exercise performance.
PURPOSE OF THE LETTER
The purpose of this letter is to provide you with information required for you to make an
informed decision regarding participation in this research.
There are no conflicts of interest to declare related to this study.
PURPOSE OF THIS STUDY
Ketosis is a physiological state where the concentration of circulating blood ketones is
elevated. Some researchers support that a state of ketosis, reached through the use of
ketogenic diet (very high fat – low carbohydrate diet), has the potential to improve
athletic performance. Recently, many endurance type athletes have engaged in
ketogenic diets, claiming that this dietary change has led to improvements in exercise
performance. A state of ketosis has been shown to be beneficial in many aspects of
health, however its effectiveness in athletic settings is rather controversial. One of the
biggest challenges to achieve and maintain ketosis is complying with the diet due to its
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restrictive nature. Consequently, manufacturers have developed supplements that can
induce a state of ketosis within 1 hour. Therefore, if ketosis is responsible for
performance improvements, these supplements should help individuals improve
performance. Unfortunately, only a handful of studies have used these supplements so
there is very little evidence supporting the use thereof to enhance athletic performance.
High blood ketones concentration seems to increase the use of ketones for energy
during physical activity. These changes in energy production may allow individuals to
spare important energy substrates, something that would be represent an advantage.
Ketone salts have been shown to elevate the concentration of ketones in blood and as
such they may allow individuals to enhance performance. Manufacturers now provide
ketones salts combined with other ingredients such as caffeine. However it is unknown
whether or not the addition of these ingredients has any positive or negative effect on
athletic performance. Caffeine alone has been shown to improve athletic performance in
several studies. Therefore, the purpose of this study is to compare the effectiveness of
a caffeine free ketone salt supplement vs a caffeinated ketone salt supplement.
INCLUSION CRITERIA
In order to be eligible to participate in this study you must be a healthy male or female
recreationally active individual, 18-35 year old, non-regular caffeine user.
EXCLUSION CRITERIA
You will be excluded from this study if you:
- Are not involved on regular exercise (at least 2x week)
- Have symptoms or take medication for respiratory, cardiovascular, metabolic,
neuromuscular disease
- Use any medications with side effects of dizziness, lack of motor control, or
slowed reaction time
- Are taking part in other research study
- For women, if you are pregnant or become pregnant during the study.
- Have a history of concussion/head injuries.
- Have an excessive alcohol intake (>2 drinks/day)
STUDY OUTLINE:
All study activities will be completed in the Exercise Nutrition Research Laboratory (Room
2235, 3M Centre). ***For the test days, you will be asked to arrive at the laboratory
at least 4 hours after ingesting your last meal. You will also be asked to refrain from
exercise and from consuming caffeine or alcohol for 24 hours prior to your study
visits. You will repeat food intake for 24 hours before each test day to equalize
energy intake for all three testing days ***
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STUDY PROCEDURES
If you volunteer to participate in this study, we will ask you to do the following things:
1. You will visit the lab for one familiarization session prior to the study days. The
familiarization session will be held at least 2 days before the first test day. This
session will involve filling out forms to ensure your safe participation in the study,
a measurement of body composition, and an acclimation to the exercise
performance tests to be used during test days. The total time required for this
session will be ~2h.
2. For the study sessions you visit the laboratory on three additional occasions. All
visits will involve the exercise testing and the consumption of one experimental
drink (drink containing ketones, drink containing ketones/caffeine or drink
containing water) 30 minutes before starting to exercise. The order of these three
experimental drinks will be randomized for each participant and they will complete
all trials. The exercise tests for all study days consists of a 20 km time trial followed
by a Wingate test.
3. We will measure blood ketones and blood lactate before ingesting the drink, 15
and 30 minutes after ingesting the drink, before starting, at 10 km and at the end
of the 20km time trial, and before, right after and 6 minutes after the Wingate test.
Therefore, we will collect a total of 9 samples during each study visit for a total of
27 samples over a 3-week period.
4. We will also measure rates of perceived exertion during the exercise tests.
Familiarization session: Before your inclusion in the study sessions, you will be
asked to fill out a physical activity readiness questionnaire and a participant information
form for personal and familial health history. This evaluation session will be held at least
2 days before the first test day. Additionally, during the familiarization session you will
have your body composition determined via BodPod® and will practice both the 20km
time trial and Wingate test. The BodPod® is a chamber which determines body volume
by measuring the space your body takes up and together with your body weight allows
us to calculate lean and fat content of the body. The 20 km time trial is essentially a race
so you would have to complete the distance as fast as possible. Finally, the Wingate test
is an all-out 30 second sprint on a bike ergometer. In this test you would have to bike as
fast as possible for 30 seconds.
Test day 1 (Total duration is approximately 2 hours): You will arrive at the exercise
nutrition lab at least 4 hours after your last meal with limited activity (drive/use of the
elevator to get to the lab).This strategy is used to ensure that you are in a rested
physiological state and thus will not affect any baseline measurements of blood ketones
or lactate concentrations. Upon arrival, the first fingerpick blood lactate and blood
ketone samples will be collected and the corresponding drink will be provided
immediately after. You will be allowed 30 minutes to read/study. The drink is a solution
containing ketones and caffeine. During those 30 minutes two more blood samples will
be taken (at 15 and 30 minutes). After this, you will perform a 10- minute standardized
warm-up and at the end we will take another fingerpick blood lactate and blood ketone
Version 1
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samples. Subsequently, exercise performance will be evaluated. The first exercise
performance test is a 20 km time trial. Blood samples and rates of perceived exertion will
be taken at 10 km and at the end of the test. After concluding this test, a 15-minute break
will be given before doing a Wingate test. Blood samples and rates of perceived exertion
will be taken at before, immediately after and 6 minutes after the end of the test.
Test day 2 and test day 3 (Total duration is approximately 2 hours): These visits will
take place at least one week after the previous study visit. You will perform the same
study procedures you did during the first study visit.
POSSIBLE RISK AND HARMS
This study involves strenuous exercise that may pose a risk of minor muscle injury,
discomfort or soreness. All exercise involves some health risk (primarily cardiovascular
or hydration-related) and you may experience symptoms of fatigue while participating in
this study. Importantly, similar exercise to that used in this study is completed by
kinesiology students and Mustang athletes daily. Further, the risks of cardiovascular
complications are much reduced in young, healthy individuals. Finally, you will be
encouraged to drink enough water to stay hydrated.
Blood Collection: Fingerprick: this method may result in some bleeding or bruising.
Pressure on the puncture site upon removal will diminish this risk.
POTENTIAL BENEFITS
Participating in this study may give you some information about your body composition,
exercise capacity, strategies to maximize performance through nutrition interventions and
if requested, you will receive you own data as well as the mean of the group.
COMPENSATION
You will not be compensated for your participation in this study. You will not be reimbursed
for additional costs such as parking or transportation.
VOLUNTARY PARTICIPATION
Participation in this study is voluntary. You may refuse to participate, refuse to answer
any questions or withdraw from the study at any time. The investigator may withdraw you
from this research if circumstances arise which warrant doing so.
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RIGHTS OF A PARTICIPANT (in the event of a study related injury)
If you suffer any study related injury during your participation in this study care will be
provided to you at no cost.
CONFIDENTIALITY
If you agree to join this study, only members of the study team will look at your personal
information (e.g., name) and collect only the information they need for the study.
The information that is collected for the study will be kept in a locked and secure area
by the study doctor for 5 years. Only the study team or the people or groups listed
below will be allowed to look at your records.
Representatives of the University of Western Ontario Health Sciences Research Ethics
Board may look at the study records and at your personal health information to check
that the information collected for the study is correct and to make sure the study
followed proper laws and guidelines.
All information collected during this study, including your personal health information,
will be kept confidential and will not be shared with anyone outside the study unless
required by law. You will not be named in any reports, publications, or presentations
that may come from this study.
If you decide to leave the study, the information about you that was collected before you
leave the study will still be used in order to answer the research question. No new
information will be collected without your permission.
CONTACT FOR FURTHER INFORMATION
If you have any questions about this research project, feel free to call us (Dr. Peter Lemon
519-661-2111 ext. 88139 or Manuel Quinones 519-661-2111 ext. 88164) for clarification.
Further, if you have any questions about the conduct of this study or your rights as a
research subject you may contact the Office of Research Ethics at Western University at
519-661-3036 or at ethics@uwo.ca.
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Consent Form
The effects of pure therapeutic ketones/caffeine free supplementation vs caffeinated
pure therapeutic ketones on a 20 Km time trial and a Wingate test exercise
performance.
Investigators: Dr. Peter W.R. Lemon and Manuel Quinones, MSc.
I have read the accompanying "Letter of Information”, have had the nature of the study
explained to me and I agree to participate. All questions have been answered to my
satisfaction.
If you wish to participate in future studies in the Exercise Nutrition Research Lab, the
research team will collect your contact information.
I wish to be contacted for future studies in the Exercise Nutrition Research Laboratory.
Yes_____ (check mark), No _____ (check mark) Date: _______________
By signing below, I agree to participate in this study.
Name of Participant (please print): _______________________________
Signature of Participant: ______________________________
Date: ______________
Name of Person Obtaining Informed Consent: __________________________
Signature of Person Obtaining Informed Consent: ________________________
Date: ______________
You will receive a copy of the consent form after it has been signed. You do not waive
any legal rights by signing the consent form.
This letter is for you to keep for future references.
Sincerely,
Dr. Peter Lemon
Manuel Quinones, MSc.
plemon@uwo.ca
mquinon2@uwo.ca
Principal Investigators
Exercise Nutrition Research Laboratory
RM 2235 3M Centre, Western University
1
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Appendix E. Letter of Information and Informed Consent study 2

Title of Study:

Effect of ketone supplementation on glycogen replenishment and
time trial performance following a glycogen lowering exercise

Principal Investigator: Dr. Peter W.R. Lemon (PhD) plemon@uwo.ca
Graduate Student: Manuel Quinones (MSc.) mquinon2@uwo.ca
Exercise Nutrition Research Laboratory (Room 2235 – 3M Centre)
School of Kinesiology, Western University.
The costs incurred in this study will be covered with laboratory funds.
LETTER OF INFORMATION AND CONSENT
INVITATION TO PARTICIPATE
You are being invited to participate in a research study at the Exercise Nutrition
Research Laboratory (Room 2235, 3M Centre) investigating the effects of ketone
supplementation on glycogen replenishment and 20 Km cycling time trial performance
following glycogen lowering exercise.
PURPOSE OF THE LETTER
The purpose of this letter is to provide you with information required for you to make an
informed decision regarding participation in this research.
There are no conflicts of interest to declare related to this study.
PURPOSE OF THIS STUDY
Carbohydrates are important for exercise at moderate to high intensities. Low glycogen
content (stored form of carbohydrates) is associated with the onset of fatigue. Thus,
greater initial glycogen content has been correlated to better performance not only in
high intensity intermittent sports, but also in prolonged endurance sports. Doseresponse studies have determined that ingestion of 1.2 g·kg-1·h-1 of CHO is the
appropriate acute recovery dose to optimize glycogen repletion, with no apparent
benefit at higher doses. Protein in combination to CHO has also been proposed to
enhance glycogen resynthesis when 1 part protein is provided with ~4 parts CHO. Both
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strategies, optimal CHO intake and CHO in combination with protein for glycogen
resynthesis, have resulted in better performance a few hours after a depleting exercise
bout. A recent study provided athletes with ketone esters after depleting exercise and
found that in the presence of high glucose availability, ketone esters increased glycogen
stores by 50% compared to a no ketone high carbohydrate treatment. However, authors
in this study provided carbohydrates using a clamp method to maintain glycaemia at
10Mm/L so it is unknown whether or not ingesting glucose at recommended dosages
would have the same effect. Furthermore, it is unknown whether or not this difference
would translate into improved performance in efforts of moderate duration. Therefore,
the purpose of this study would be to assess the effect of glucose-ketone
supplementation on a 20 km time trial after a 2-hour feeding / 4-hour recovery period
following glycogen depleting exercise.
INCLUSION CRITERIA
In order to be eligible to participate in this study you must be a healthy male or female
trained active individual (at least 1y training experience – at least 3x week), 18-40 year
old.
EXCLUSION CRITERIA
You will be excluded from this study if you:
- Are not involved on regular exercise (at least 3x week)
- Have symptoms or take medication for respiratory, cardiovascular, metabolic,
neuromuscular disease
- Use any medications with side effects of dizziness, lack of motor control, or
slowed reaction time
- Are taking part in other research study
- For women, if you are pregnant or become pregnant during the study.
- Have a history of concussion/head injuries.
- Have an excessive alcohol intake (>2 drinks/day)
- Smoker
STUDY OUTLINE
All study activities will be completed in the Exercise Nutrition Research Laboratory (Room
2235, 3M Centre). ***For the test days, you will be asked to arrive at the laboratory at
7:30 am following an overnight fast (no food or drink except water after 7:30pm). You will
also be asked to refrain from exercise and from consuming caffeine or alcohol for 24
hours prior to your study visits. You will record everything you eat and drink 2 days before
the experimental day in order to duplicate both nutrient and energy intake for the second
experimental day. ***
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STUDY PROCEDURES
If you volunteer to participate in this study, we will ask you to do the following things:
1. You will visit the lab for two familiarization sessions prior to the two study days.
The familiarization sessions will be held on separate days and at least 2 days
before the first test day. The first session will involve filling out forms to ensure your
safe participation in the study, a measurement of body composition, and an
incremental cycling test to determine maximum oxygen consumption and
maximum power output. On a second visit, you will be familiarized with the
exercise testing to be used in the experimental days. The total time required per
session will be ~2h.
2. For the study sessions you visit the laboratory on two additional occasions. Both
visits will involve a glycogen depletion cycling protocol, the exercise testing and
the consumption of one experimental drink (drink containing ketones and
carbohydrates or drink containing carbohydrates alone). The order of these
experimental drinks will be randomized for each participant and they will complete
all trials. The exercise test to be used in study days consists of a 20 km cycling
time trial.
3. We will take blood samples to measure blood ketones and insulin before ingesting
the drink, and every 30 minutes for a period of 2 hours. Therefore, we will collect
a total of 5 samples during each study visit for a total of 10 (5 per experiment)
samples over a 2-week period. All sampling will be obtained using a catheter from
antecubital vein into EDTA containing tubes and only requires 5ml of blood (1
teaspoon).
4. We will also measure rates of perceived exertion and gas exchange during the
20 km cycling time trial.
Familiarization session: Before your inclusion in the study sessions, you will be asked to
fill out a physical activity readiness questionnaire and a participant information form for
personal and familial health history. This evaluation session will be held at least 2 days
before the second familiarization session. Additionally, during this session session you
will have your body composition determined via BodPod® and will perform an
incremental cycle exercise test to volitional exhaustion to determine the individual
maximum power output (Wmax) and maximal oxygen consumption (VO2 max). The
BodPod® is a air filled chamber (~volume = 600 litres) which determines body volume
by measuring the air your body displaces. Together with your body weight we calculate
body density which enables us to estimate your lean and fat body content. For this test,
you will remain seated, keeping still and breathing normally. The test takes 45 seconds
and is usually done several times for accuracy. You will asked if you are okay after
each test. There is a window that allows you to see outside which eliminates
claustrophobic issues for most. Further, there is a panic button so you can end the test
at any time. The incremental cycle exercise test will be performed on an
electromagnetically braked cycle ergometer (Velotron, RacerMate, Inc., Seattle,
Washington, USA) with cycling starting at 95 W for 3 min, followed by incremental steps
of 35 W every 3 min until exhaustion. Breath-by-breath on line analysis of O2 and CO2
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will be carried out using open-circuit metabolic cart (Vmax Legacy, Sensor Medics, CA,
USA). Heart rate (HR) will be recorded using a HR monitor (Polar RS200TM, Polar Electro
Inc., Lachine, Canada). Wmax will be calculated from the last completed work rate, plus
the fraction of time spent in the final non-completed work rate multiplied by the work rate
increment. In a second familiarization session, you will practice the 20 km time trial to be
used in testing days to assess performance. The 20 km cycling time trial is essentially a
race so you complete the 20km, as fast as possible.
Test day 1 (Total duration is approximately 7 hours): You will arrive at the exercise
nutrition lab at 7:30 am following an overnight fast, and with limited activity (drive/use of
the elevator to get to the lab).This strategy is used to ensure that you are in a rested
physiological state and thus will not affect any baseline measurements. Upon arrival, a
fingerpick blood ketone sample will be collected. Then, you will engage in a standardized
glycogen depleting exercise protocol. This protocol begins with a 10 minute warm up
period at a workload of 50% Wmax. Thereafter, you will be instructed to cycle 2-min block
periods at alternating workloads of 90% and 50% of Wmax, respectively. This will be
continued until you are no longer able to complete the 2 min at 90% Wmax. That moment
will be defined as the time at which you are unable to maintain cycling speed at 60
revolutions/min. At that moment the high-intensity block will be reduced to 80% Wmax.
Again, you will cycle until you are unable to complete a 2-min block at 80% Wmax, after
which the high-intensity block will be reduced to 70% Wmax. Similarly, when unable to
maintain 70%, the workload will be reduced to 60%. You will be allowed to stop when
pedalling speed could not be maintained at 60% Wmax. Water will be provided ad libitum
during the exercise protocol. The corresponding drinks will be provided during a 2-hour
feeding period immediately after cessation of the depleting exercise. The first drink
consist of either ketone supplementation or isocaloric carbohydrate supplementation,
followed by a carbohydrate containing drink every 15 minutes for the duration of the 2
hour feeding period (9 drinks in total). Immediately before the start of the recovery drinks
and every 30 min throughout the 2h feeding period 5 ml blood (1 teaspoon) will be
collected by certified personnel via venipuncture using a catheter from antecubital vein
into EDTA containing tubes and processed to measure plasma ketones (mmol/L) and
insulin (pmol/L) using FreeStyle Precision Neo® ketone meter (Abbott Diabetes Care
Limited, Saint-Laurent, Quebec) and a standard insulin radioimmunoassay kit,
respectively. After this, you will be allowed a 2-hour recovery period before initiating a
performance evaluation. Exercise performance will be assessed with a 20 km cycling time
trial. Gas exchange and rates of perceived exertion will be collected during this test.
Test day 2 (Total duration is approximately 7 hours): This visit will take place at least one
week after the previous study visit. You will perform the same study procedures you did
during the first study visit.
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POSSIBLE RISK AND HARMS
This study involves strenuous exercise that may pose a risk of minor muscle injury,
discomfort or soreness. All exercise involves some health risk (primarily cardiovascular
or hydration-related) and you may experience symptoms of fatigue while participating in
this study. Importantly, similar exercise to that used in this study is completed by
kinesiology students and Mustang athletes daily. Further, the risks of cardiovascular
complications are much reduced in young, healthy individuals. Finally, you will be
encouraged to drink enough water to stay hydrated.
Blood Collection: There will be some risk or discomfort involved in this study as a
catheter will be inserted in your forearm by a certified professional in order to draw
about 1 teaspoon of blood. This method may result in some bleeding or bruising.
Pressure on the puncture site upon removal will diminish this risk.
POTENTIAL BENEFITS
No direct benefits are likely from participating in this study.
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COMPENSATION
You will not be compensated for your participation in this study. You will not be reimbursed
for additional costs such as parking or transportation.
VOLUNTARY PARTICIPATION
Participation in this study is voluntary. You may refuse to participate, refuse to answer
any questions or withdraw from the study at any\ time with no effect to your academic
status. You can also choose to remove your data from the study should you wish to do
so. The investigator may withdraw you from this research if circumstances arise which
warrant doing so. For example, if you cannot comply with the study protocol, or if you
start/follow a ketogenic diet or for women, if you become pregnant during the study.
RIGHTS OF A PARTICIPANT (in the event of a study related injury)
If you suffer any study related injury during your participation in this study care will be
provided to you at no cost.
CONFIDENTIALITY
If you agree to join this study, only members of the study team will look at your personal
information (e.g., name) and collect only the information they need for the study.
The information that is collected for the study will be kept in a locked and secure area
by the study doctor for 7 years. Only the study team or the people or groups listed
below will be allowed to look at your records.
Representatives of the University of Western Ontario Health Sciences Research Ethics
Board may look at the study records and at your personal health information to check
that the information collected for the study is correct and to make sure the study
followed proper laws and guidelines.
All information collected during this study, including your personal health information,
will be kept confidential and will not be shared with anyone outside the study unless
required by law. You will not be named in any reports, publications, or presentations
that may come from this study.
If you decide to leave the study, the information about you that was collected before you
leave the study will still be used in order to answer the research question. No new
information will be collected without your permission.
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CONTACT FOR FURTHER INFORMATION
If you have any questions about this research project, feel free to call us (Dr. Peter Lemon
519-661-2111 ext. 88139 or Manuel Quinones 519-661-2111 ext. 88164) for clarification.
Further, if you have any questions about the conduct of this study or your rights as a
research subject you may contact the Office of Research Ethics at Western University at
519-661-3036 or at ethics@uwo.ca.
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Consent Form
Effect of ketone supplementation on glycogen replenishment and time trial performance
following a glycogen lowering exercise
Investigators: Dr. Peter W.R. Lemon and Manuel Quinones, MSc.
I have read the accompanying "Letter of Information”, have had the nature of the study
explained to me and I agree to participate. All questions have been answered to my
satisfaction.
If you wish to participate in future studies in the Exercise Nutrition Research Lab, the
research team will collect your contact information.
I wish to be contacted for future studies in the Exercise Nutrition Research Laboratory.
Yes_____ (check mark), No _____ (check mark) Date: _______________
By signing below, I agree to participate in this study.
Name of Participant (please print): _______________________________
Signature of Participant: ______________________________
Date: ______________
Name of Person Obtaining Informed Consent: __________________________
Signature of Person Obtaining Informed Consent: ________________________
Date: ______________
You will receive a copy of the consent form after it has been signed. You do not waive
any legal rights by signing the consent form.
This letter is for you to keep for future references.
Sincerely,
Dr. Peter Lemon
Manuel Quinones, MSc.
plemon@uwo.ca
mquinon2@uwo.ca
Principal Investigators
Exercise Nutrition Research Laboratory
RM 2235 3M Centre, Western University
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Appendix F. Letter of Information and Informed Consent study 3

Title of Study:

The effect of exogenous ketone supplementation on cognitive
function during exercise after induced mental fatigue

Principal Investigator: Dr. Peter W.R. Lemon (PhD) plemon@uwo.ca
Graduate Student: Manuel Quinones (PhD Candidate.) mquinon2@uwo.ca
Exercise Nutrition Research Laboratory (Room 414 – Health Science Building)
School of Kinesiology, Western University.
This study is a student project and the costs incurred in this study will be covered with
laboratory funds.
LETTER OF INFORMATION AND CONSENT
INVITATION TO PARTICIPATE
You are being invited to participate in a research study at the Exercise Nutrition Research
Laboratory (Room 414 – Health Science Building) investigating the effects of ketone
(breakdown products of fat metabolism) supplementation on cognitive function during
exercise after induced mental fatigue.
PURPOSE OF THE LETTER
The purpose of this letter is to provide you with the information required for you to make
an informed decision regarding participation in this research.
There are no conflicts of interest to declare related to this study.
PURPOSE OF THIS STUDY
Carbohydrates (starches & sugars) are important muscle and brain fuel for exercise at
moderate to high intensities. Low content of carbohydrates (CHO) is often associated
with fatigue. Thus, greater amount of CHO before or during activity has been associated
with better performance not only in high intensity intermittent sports, but also in
prolonged endurance sports. Soccer specifically is a very demanding sport, not only
physically, but also cognitively. Therefore, it is not surprising to see a deterioration in
decision making and skill performance towards the end of a soccer match. Exogenous
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ketone esters are a commercially available supplement that have been shown to
potentially help preserve CHO as well as to serve as an alternative fuel for the brain.
Research investigating the effects of ketones on performance in general are rather
controversial. This inconsistency in the results has been attributed to differences in
supplements (esters vs salts), methodology, as well as the dose administered in those
studies. Some positive results in cognitive function have been observed with the use of
ketone esters during endurance exercise. However, whether the effects of exogenous
ketone esters are similar during high intensity, intermittent exercise, like that performed
in a soccer game, is still unknown. Therefore, the purpose of the present study is to
assess whether ketone ester supplementation can enhance cognitive performance later
in a simulated soccer game after induced mental fatigue.
INCLUSION CRITERIA
In order to be eligible to participate in this study you must be a healthy male or female
recreationally active individual, 18-35 year old.
EXCLUSION CRITERIA
You will be excluded from this study if you:
- Are not involved in regular exercise (at least 2x week)
- Have symptoms or take medication for respiratory, cardiovascular, metabolic,
neuromuscular disease
- Use any medications with side effects of dizziness, lack of motor control, or
slowed reaction time
- Are taking part in another research study
- For women, if you are pregnant or become pregnant during the study.
- Have a history of concussion/head injuries.
- Have an excessive alcohol intake (>2 drinks/day)
- Are consuming a ketogenic diet (for at least 2 weeks)
- Are a smoker
- ** Cannabis use is not a exclusion criteria; however, it must be avoided on
experimental days.**
STUDY OUTLINE
All study activities will be completed in the Exercise Nutrition Research Laboratory (Room
414 – Health Science Building). ***For the test days, you will be asked to arrive at the
laboratory at least 4 hours after ingesting your last meal. You will also be asked to refrain
from exercise and from consuming caffeine or alcohol for 24 hours prior to your study
visits. Also, you will need to record everything you eat and drink (type and quantities) 24
hours before the experimental day in order to repeat both food and fluid intake for the
second experimental day. ***
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STUDY PROCEDURES
If you volunteer to participate in this study, you will to do the following:
1. Visit the lab for two familiarization sessions prior to the two study days. The
familiarization sessions will be held on separate days and at least 2 days before
the first test day. The first session will involve filling out forms to ensure your safe
participation in the study, a measurement of body composition, a maximum oxygen
consumption test and a sprint test to determine the treadmill speeds to be used
during study days. The second familiarization session will be used to acclimate
you to the running exercise intensities and to practice the cognitive tests. The total
time required for the two familiarization sessions will be ~3h.
2. For the study sessions you visit the laboratory on two additional occasions. Both
visits will involve a mental fatiguing task (MFT), ingestion of one experimental drink
(drink containing ketone esters or iso-caloric drink containing carbohydrates alone)
and executing cognitive tests while running. The running exercise for both study
days consists of a 45 - minute half simulated soccer game divided into 3 x 15minute blocks running at varying intensities that replicate the activity pattern of
soccer such as sprinting, jogging, cruising, walking etc. The order of these
experimental trials will be randomized, and you will complete both trials.
3. Visual analog scales (VAS) to assess mental fatigue will be used before and after
the MFT. Also, motivation to exercise and mental effort will be assessed using VAS
at the end of the MFT.
4. Capillary blood samples for ketones, glucose and lactate will be taken before and
after the mental fatiguing task, right before starting the running exercise, and every
15 minutes at the end of each exercise block. i.e., 6 fingerprick samples will be
taken during each study visit for a total of 12 samples over a 2-week period.
5. Perceived exertion ratings will be taken at the end of each exercise block and
cognitive function will be assessed within each block during the 45- minute running
exercise.
Familiarization session 1: You will be asked to fill out a physical activity readiness
questionnaire and a participant information form for personal and familial health history.
You will also have your body composition determined via BodPod® and will perform an
incremental running exercise test to voluntary fatigue to determine your maximal oxygen
consumption (VO2 max).
The BodPod® is a air filled chamber (~volume = 600 litres) which determines body
volume by measuring the air your body displaces. Together with your body mass we
calculate body density which enables us to estimate your lean and fat body content. You
will remain seated, keeping still and breathing normally. The test takes 45 seconds and
is usually done several times for accuracy. There is a window that allows you to see
outside which eliminates claustrophobic issues for most. Further, there is a panic button
so you can end the test at any time.
The maximal oxygen consumption test involves a continuous, incremental test on a
treadmill until you reach volitional fatigue. Breath-by-breath online analysis of O2 and CO2
will be carried out using an open-circuit metabolic cart (Vmax Legacy, Sensor Medics,
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CA, USA). Heart rate (HR) will be recorded using a HR monitor (Polar RS200TM, Polar
Electro Inc., Lachine, Canada).
Familiarization session 2: You will be running one 15-minute block exercise to acclimate
to the running intensities that will be used during the study, and will practice the cognitive
tests to remove any learning effect.
Test day 1 (approximately 2 hours): You will arrive at the exercise nutrition lab at least 4
hours after your last meal with limited activity (drive/use of the elevator to get to the
lab).This strategy is used to ensure that you are in a rested physiological state and thus
will not affect any baseline measurements of blood glucose, ketones or lactate
concentrations. Upon arrival, the first fingerpick blood sample will be collected. Then,
mental fatigue will be assessed and right after the MFT will begin. This task has a duration
of 30 minutes and involves performing the Stroop test during this time. At the end of the
MFT, mental fatigue, mental effort and motivation will be assessed using VAS. Next,
cognitive function will be assessed using both the Stroop test and the Complex reaction
time test. A fingerpick blood sample will be collected and the corresponding drink will be
provided immediately after. You will be given 10 minutes before the warm-up starts. The
drink is a solution containing either ketone esters or sugar (dextrose). After this, you will
perform a 5- minute standardized warm-up and begin the 45-minute half simulated soccer
match. Right before starting the soccer match simulation, a fingerpick blood sample and
rate of perceived exertion (RPE) will be collected. Cognitive function will be assessed
during the 45-minute running exercise. Blood samples and RPE will be collected at the
end of each 15-minute exercise block (Figure 1).
Test day 2 (approximately 2 hours): This visit will take place at least one week after the
previous study visit. You will perform the same study procedures you did during the first
study visit but with the other drink.
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Figure 1. Experimental protocol. VO2max = maximal oxygen consumption, (
sampling, (

) = Cognitive function measures, RPE (

) = blood

) = rating of perceived exertion,

= ketone ester supplement.
POSSIBLE RISK AND HARMS
This study involves strenuous exercise that may pose a risk of minor muscle injury,
discomfort or soreness. All exercise involves some health risk (primarily cardiovascular
or hydration-related) and you may experience symptoms of fatigue while participating in
this study. Importantly, similar exercise to that used in this study is completed by
kinesiology students and Mustang athletes daily. Further, the risks of cardiovascular
complications are much reduced in young, healthy individuals. Finally, you will be
encouraged to drink enough water to stay hydrated.
Blood Collection: Fingerprick: this method may result in some bleeding or bruising.
Pressure on the puncture site upon removal will diminish this risk.
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POTENTIAL BENEFITS
No direct benefits are likely from participating in this study.
COMPENSATION
You will not be compensated for your participation in this study nor will you be reimbursed
for any additional costs such as parking or transportation.
VOLUNTARY PARTICIPATION
Participation in this study is voluntary. You may refuse to participate, refuse to answer
any questions or withdraw from the study at any\ time with no effect to your academic or
work status. You can also choose to remove your data from the study should you wish to
do so. The investigator may withdraw you from this research study if circumstances arise
which warrant doing so, i.e., if you cannot comply with the study protocol.
RIGHTS OF A PARTICIPANT (in the event of a study related injury)
If you suffer a study related injury during your participation in this study care will be
provided to you at no cost.
CONFIDENTIALITY
Only members of the study team will look at your personal information (e.g., name) and
collect only the information they need for the study.
All information that is collected for the study will be kept in a locked and secure area by
the study doctor for 7 years. Only the study team (listed below under the Contact for
Further Information) will be allowed to look at your records. Further, you will be
identified with a study number so your records will not be easily connected to you.
Finally, the master file identifying you will be encrypted and stored separately on a
University server behind a firewall.
Representatives of the University of Western Ontario Health Sciences Research Ethics
Board may look at the study records and at your personal health information to check
that the information collected for the study is correct and to make sure the study
followed proper laws and guidelines.
All information collected during this study, including your personal health information,
will be kept confidential and will not be shared with anyone outside the study unless
required by law. You will not be named in any reports, publications, or presentations
that may come from this study.
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If you decide to leave the study, the information about you that was collected before you
leave the study will still be used in order to answer the research question. No new
information will be collected without your permission.

CONTACT FOR FURTHER INFORMATION
If you have any questions about this research project, feel free to call us (Dr. Peter Lemon
519-661-2111 ext. 88139 or Manuel Quinones 519-661-2111 ext. 88164) for clarification.
Further, if you have any questions about the conduct of this study or your rights as a
research subject you may contact the Office of Research Ethics at Western University at
519-661-3036 or at ethics@uwo.ca.
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Consent Form
The effect of exogenous ketone supplementation on cognitive function during exercise
after induced mental fatigue
Investigators: Dr. Peter W.R. Lemon and Manuel Quinones, MSc.
I have read the accompanying "Letter of Information”, have had the nature of the study
explained to me and I agree to participate. All questions have been answered to my
satisfaction.
If you wish to participate in future studies in the Exercise Nutrition Research Lab, the
research team will collect your contact information.
I wish to be contacted for future studies in the Exercise Nutrition Research Laboratory.
Yes_____ (check mark), No _____ (check mark) Date: _______________
By signing below, I agree to participate in this study.
Name of Participant (please print): _______________________________
Signature of Participant: ______________________________
Date: ______________
Name of Person Obtaining Informed Consent: __________________________
Signature of Person Obtaining Informed Consent: ________________________
Date: ______________
You will receive a copy of the consent form after it has been signed. You do not waive
any legal rights by signing the consent form.
This letter is for you to keep for future references.
Sincerely,
Dr. Peter Lemon
Manuel Quinones, MSc.
plemon@uwo.ca
mquinon2@uwo.ca
Principal Investigators
Exercise Nutrition Research Laboratory
RM 414 Health Science Building, Western University
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